Hydronephrosis

N14_HYDRONEPHR

hydronephrosis: Collection of urine in the renal pelvis that results in dilatation of the renal pelvis and calyces. It is caused by obstruction of urine flow, nephrolithiasis, or vesicoureteral reflux. Signs and symptoms include flank pain, nausea, vomiting, fever, and dysuria.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — N13.0, N13.1, N13.2, N13.3 Hospital discharge: ICD-9 — 591 Hospital discharge: ICD-8 — 591 Cause of death: ICD-10 — N13.0, N13.1, N13.2, N13.3 Cause of death: ICD-9 — 591 Cause of death: ICD-8 — 591 2 out of 7 registries used, show all original rules.	4676
4. Check minimum number of events None	4676
5. Include endpoints None	4676
6. Filter based on genotype QC (FinnGen only)	4676

Control definitions (FinnGen only)

Control exclude: N14_RENALTUB

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2

NAME	N14_HYDRONEPHR
CONTROL_EXCLUDE	N14_RENALTUB
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	N13[0-3]
HD_ICD_9	591
HD_ICD_8	591
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	N13[0-3]
COD_ICD_9	591
COD_ICD_8	591
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Hydronephrosis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	36341	17231	18729
Only index persons	29748	14472	15276
Unadjusted period prevalence (%)
Whole population	0.51	0.49	0.52
Only index persons	0.56	0.53	0.58
Median age at first event (years)
Whole population	64.20	61.27	66.85
Only index persons	62.75	59.10	66.22

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	4676	2220	2456
Unadjusted period prevalence (%)	0.93	0.76	1.08
Median age at first event (years)	62.88	56.43	68.71

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
4162: Matched controls
41617

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

516.4

323.0

801

KA1FN

NOMESCO Finland

Isotope renography

113.1

323.0

371

KBV15

NOMESCO Finland

Cystoscopic change of ureteral stent

230.7

323.0

397

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

20.2

323.0

1036

672

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

90.5

323.0

1261

199

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

16384.0

323.0

3097

KA1AE

NOMESCO Finland

Kidney ultrasound examination

31.2

323.0

514

187

N13.0

ICD-10 Finland

Hydronephrosis with ureteropelvic junction obstruction

+∞

323.0

710

N13.1

ICD-10 Finland

Hydronephrosis with ureteral stricture, not elsewhere classified

+∞

323.0

369

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

33.5

323.0

511

173

KBV12

NOMESCO Finland

Transluminal endoscopic removal of stent from ureter

89.4

323.0

726

UKB02

NOMESCO Finland

Retrograde ureteroscopy

56.1

323.0

447

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

72.9

323.0

1421

293

KH1FT

NOMESCO Finland

Exchange of urinary catheter with radiological guidance

833.9

323.0

380

UKC02

NOMESCO Finland

Cystoscopy

8.7

323.0

1965

3894

KA3EB

NOMESCO Finland

Antegrade pyelography

398.6

323.0

367

KH1AD

NOMESCO Finland

CT of urinary organs

14.4

317.4

560

443

J01MA02

ATC

ciprofloxacin; systemic

3.6

315.1

2235

10226

KBV10

NOMESCO Finland

Removal of stent from ureter

81.0

310.7

350

N17.9

ICD-10 Finland

Acute renal failure, unspecified

258.3

306.3

311

5910A

ICD-9 Finland

Hydronephrosis[HYDRONEPHROSIS]

+∞

282.5

268

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

5.0

279.6

1047

2638

KH1AA

NOMESCO Finland

Urinary tract X-ray examination without contrast

30.7

278.7

378

135

N20.1

ICD-10 Finland

Calculus of ureter

10.4

278.5

577

632

N13.9

ICD-10 Finland

Obstructive and reflux uropathy, unspecified

929.9

269.8

262

N18.8

ICD-10 Finland

Other chronic renal failure

64.1

265.0

309

R31

ICD-10 Finland

Unspecified haematuria

5.1

255.5

920

2198

KBV00

NOMESCO Finland

Insertion of stent into ureter

115.0

248.5

269

KH1YT

NOMESCO Finland

Percutaneous implantation of endoprothesis with radiological guidance

508.8

244.1

241

N13.2

ICD-10 Finland

Hydronephrosis with renal and ureteral calculous obstruction

+∞

241.0

229

N20.0

ICD-10 Finland

Calculus of kidney

16.7

237.7

392

257

J01EA01

ATC

trimethoprim; systemic

3.4

236.4

1484

5818

R33

ICD-10 Finland

Retention of urine

5.3

214.6

724

1581

JN3AD

NOMESCO Finland

Abdominal CT examination

5.9

212.4

649

1258

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

101.9

202.4

222

KCD02

NOMESCO Finland

Transurethral resection of bladder

11.0

194.5

387

383

N02AA05

ATC

oxycodone; systemic

3.7

191.2

992

3255

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

54.5

189.5

227

59199

ICD-8 Finland

Hydronephrosis

+∞

178.4

170

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

11.5

170.3

330

308

A03FA01

ATC

metoclopramide; systemic, rectal

3.0

167.9

1210

4996

Z51.5

ICD-10 Finland

Palliative care

5.3

162.8

542

1144

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

75.9

160.0

182

U14

ICPC

Kidney symptom/complaint

23.0

157.4

231

106

B01AB10

ATC

tinzaparin; parenteral

5.1

156.5

541

1188

J01MA12

ATC

levofloxacin; systemic

3.0

153.5

1085

4379

WX408

NOMESCO Finland

General anesthesy, balanced

2.7

153.4

1433

6880

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

7.7

153.0

375

527

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.5

151.4

803

2628

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

6.4

149.7

419

711

JN4AD

NOMESCO Finland

Body CT examination

4.5

149.5

582

1444

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

11.1

149.1

294

283

KBE12

NOMESCO Finland

Transluminal endoscopic extraction of calculus of ureter

20.2

145.0

222

116

N19

ICD-10 Finland

Unspecified kidney failure

13.9

142.0

251

191

XKD00

NOMESCO Finland

Uroflowmetry

2.9

141.6

1033

4226

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

6.4

139.5

389

655

WX302

NOMESCO Finland

Thoracal epidural anesthesy

5.5

138.9

442

878

Q62.10

ICD-10 Finland

Congenital unilateral occlusion of the pelvic ureteral junction

183.6

136.4

142

H02AB02

ATC

dexamethasone; systemic

3.6

135.6

697

2207

JN4BD

NOMESCO Finland

Extensive body CT

3.5

135.4

737

2441

KH1BD

NOMESCO Finland

Extensive urinary tract CT examination

23.0

135.2

198

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.7

134.7

657

1991

A11CC03

ATC

alfacalcidol; systemic

22.7

133.8

197

TKC20

NOMESCO Finland

Catheterisation of bladder

4.4

133.4

532

1344

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

11.9

131.9

251

224

N18.0

ICD-10 Finland

End-stage renal disease

+∞

129.8

124

Z49.1

ICD-10 Finland

Extracorporeal dialysis

141.6

129.0

137

KH1CD

NOMESCO Finland

Very extensive urinary tract ultrasound examination

15.8

128.5

215

143

TK800

NOMESCO Finland

Hemodialysis

23.7

128.2

186

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

11.2

127.5

249

234

ZXD05

NOMESCO Finland

Urgent procedure

2.4

125.6

1523

8199

N20.9

ICD-10 Finland

Urinary calculus, unspecified

8.1

123.2

290

380

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

3.0

122.7

834

3219

KA3GB

NOMESCO Finland

Retrograde pyelography

113.5

121.7

132

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

9.8

121.2

254

273

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

5.0

121.1

418

906

N30.0

ICD-10 Finland

Acute cystitis

3.2

120.9

731

2598

KAH41

NOMESCO Finland

Percutaneous endoscopic pyeloureteroplasty with division of ureteropelvic junction

409.0

120.3

120

KBH20

NOMESCO Finland

Replantation of ureter

132.0

119.8

128

JN3BD

NOMESCO Finland

Extensive abdominal CT

3.4

116.1

645

2150

130

Kela drug reimbursment

Malignant tumour

3.5

114.2

591

1863

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.2

113.9

1602

9147

B03XA02

ATC

darbepoetin alfa; parenteral

18.6

112.8

177

UKA02

NOMESCO Finland

Retrograde ureteronephroscopy

41.4

111.2

140

A04AA02

ATC

granisetron; systemic, transdermal

4.4

110.4

439

1096

KAT00

NOMESCO Finland

Extracorporeal shock wave lithotripsy of pelvis of kidney

15.9

108.1

180

118

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

278.0

106.4

108

TPH04

NOMESCO Finland

Cathetrisation of vein

2.5

104.7

1029

4887

A12AA04

ATC

calcium carbonate; oral

28.8

103.6

142

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

3.6

102.9

506

1523

WW500

NOMESCO Finland

Blood transfusion

5.5

101.8

320

620

N13.8

ICD-10 Finland

Other obstructive and reflux uropathy

+∞

100.4

TPX10

NOMESCO Finland

Implantation of vascular injection port

7.8

99.8

240

324

V03AE01

ATC

polystyrene sulfonate; oral

31.9

99.7

133

R50.9

ICD-10 Finland

Fever, unspecified

2.8

98.9

715

2832

Z94.0

ICD-10 Finland

Kidney transplant status

52.7

98.3

118

C03CA01

ATC

furosemide; systemic

2.2

97.8

1381

7767

KAE12

NOMESCO Finland

Retrograde ureteronephroscopic lithotripsy in pelvis of kidney

27.6

96.8

134

KBJ10

NOMESCO Finland

Cutaneous ureteroenterostomy

29.4

96.2

131

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.0

95.1

1913

12418

128

Kela drug reimbursment

Cancers of female genital organs

9.9

94.2

196

207

N17.8

ICD-10 Finland

Other acute renal failure

462.6

91.6

7143

FHL

Pyeloureteroplasty

897.2

90.1

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

2.1

88.7

1460

8676

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

227.2

86.7

SPAT1262

SPAT

Handing over of treatment supplies

2.4

85.2

888

4283

TPH07

NOMESCO Finland

Cathetrisation of artery

2.9

84.4

561

2087

L01BC06

ATC

capecitabine; oral

5.0

82.5

281

594

Z49.0

ICD-10 Finland

Preparatory care for dialysis

126.9

81.2

A04AA01

ATC

ondansetron; systemic, rectal

3.5

80.4

409

1254

WZC30

NOMESCO Finland

Teaching

2.6

79.8

664

2829

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.5

79.5

738

3337

N20.2

ICD-10 Finland

Calculus of kidney with calculus of ureter

30.5

79.5

107

KAH40

NOMESCO Finland

Pyeloureteroplasty with division of ureteropelvic junction

+∞

79.4

1530

FHL

Urethrocystoscopy

7.0

78.7

203

303

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

11.4

78.0

150

136

A41.9

ICD-10 Finland

Sepsis, unspecified

5.4

78.0

246

476

WF049

NOMESCO Finland

Radiotherapy of metastasis

5.0

77.9

266

563

B01AB05

ATC

enoxaparin; parenteral

2.0

77.7

1345

8051

N30.9

ICD-10 Finland

Cystitis, unspecified

4.2

77.4

316

801

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

85.8

75.2

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

6.9

74.7

195

296

ZX120

NOMESCO Finland

Intravenous

2.9

74.7

501

1869

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

84.7

74.2

J01CA08

ATC

pivmecillinam; oral

1.9

74.0

1464

9174

UKC05

NOMESCO Finland

Cystoscopy and bladder biopsy

11.5

73.4

140

125

ZXE10

NOMESCO Finland

More than one and less than three hours

1.9

72.2

1566

10123

5901A

ICD-9 Finland

Infections of kidney, Acute pyelonephritis

+∞

72.1

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

14.3

71.8

124

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

41.3

70.9

KED22

NOMESCO Finland

Transurethral resection of prostate

3.2

70.9

407

1363

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

4.1

70.0

290

744

ZXE20

NOMESCO Finland

More than three and less than five hours

2.4

69.7

695

3241

G04CA02

ATC

tamsulosin; oral

2.0

69.5

1188

7015

127

Kela drug reimbursment

Transplant complication

16.0

69.1

114

U70

ICPC

Pyelonephritis/pyelitis

17.4

67.0

107

C66

ICD-10 Finland

Malignant neoplasm of ureter

61.1

66.7

KCC10

NOMESCO Finland

Cystoprostatectomy

21.5

66.7

A41.8

ICD-10 Finland

Other specified sepsis

9.0

66.1

144

165

WX402

NOMESCO Finland

General anaesthesia

2.2

65.9

744

3674

SPAT1125

SPAT

Stoma care and guidance

8.1

65.9

153

195

J01DB01

ATC

cefalexin; oral

1.9

65.8

3238

27020

N02BE01

ATC

paracetamol; systemic, rectal

2.0

64.7

3456

29591

59010

ICD-8 Finland

Infections of kidney, Pyelonephritis

+∞

64.7

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

9.1

64.6

140

159

JAH00

NOMESCO Finland

Laparotomy

5.0

64.5

217

451

N02AX02

ATC

tramadol; systemic, rectal

1.8

63.9

1727

11868

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

4.7

63.8

230

515

KCW02

NOMESCO Finland

Lavation of bladder for coagulated blood

10.5

62.7

125

122

SPAT1255

SPAT

Intravenous administration of medicine

3.2

60.5

347

1156

SPAT1167

SPAT

Insertion of urinary catheter

4.5

59.7

221

508

XX3DW

NOMESCO Finland

Time consuming IT work

2.5

59.6

512

2196

U29

ICPC

Urinary symptom/complaint other

5.1

59.4

197

403

137

Kela drug reimbursment

Uraemia requiring dialysis

48.8

59.4

U99

ICPC

Urinary disease other

19.0

58.9

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

5.2

58.7

190

378

L03AA13

ATC

pegfilgrastim; parenteral

4.1

58.5

240

609

V03AE02

ATC

sevelamer; oral

295.9

57.4

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

4.0

57.3

244

641

116

Kela drug reimbursment

Prostate cancer

2.8

57.1

400

1521

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.0

56.4

818

4473

L04AA06

ATC

mycophenolic acid; systemic

10.7

56.4

111

106

163

Kela drug reimbursment

Abiraterone and enzalutamide

7.9

56.3

132

171

D41.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Ureter

89.9

56.0

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.5

55.9

500

2188

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.8

55.0

1295

8409

TKC10

NOMESCO Finland

Percutaneous puncture of bladder

8.2

54.6

125

156

C61

ICD-10 Finland

Malignant neoplasm of prostate

2.3

53.9

571

2714

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

115.5

52.9

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

2.3

52.8

550

2592

ZXE00

NOMESCO Finland

One hour or less

1.7

52.8

1601

11196

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

56.2

51.7

A02BC02

ATC

pantoprazole; systemic

1.6

51.6

2525

20106

196

Kela drug reimbursment

Paricalcitol and cinacalcet

514.1

51.5

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.9

50.9

849

4875

N21.0

ICD-10 Finland

Calculus in bladder

8.2

49.9

114

142

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

10.4

49.2

J01MA06

ATC

norfloxacin; oral

2.2

49.0

574

2852

L02BB03

ATC

bicalutamide; oral

3.7

48.6

226

640

KBT00

NOMESCO Finland

Extracorporeal shock wave lithotripsy of ureter

19.3

48.4

TKC22

NOMESCO Finland

Catheterisation instruction

5.2

48.3

156

310

U05

ICPC

Urination problems other

3.4

48.3

246

749

KH1RT

NOMESCO Finland

Urinary tract dilatatation with radiological guidance

168.6

47.9

U28

ICPC

Limited function/disability (U)

10.2

47.7

PJD54

NOMESCO Finland

Block dissection of iliac lymph nodes

10.2

47.7

WF004

NOMESCO Finland

Palliative radiotherapy

5.3

47.4

149

287

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

126.5

46.8

KH1AT

NOMESCO Finland

Urinary tract cathetrisation with ultrasound guidance

31.4

46.7

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.0

46.6

660

3545

Z93.6

ICD-10 Finland

Other artificial openings of urinary tract status

462.7

46.4

M05BX04

ATC

denosumab; parenteral

3.2

46.2

256

830

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

4.5

46.1

170

389

N13.5

ICD-10 Finland

Kinking and stricture of ureter without hydronephrosis

+∞

45.9

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

232.4

45.0

TJF80

NOMESCO Finland

Ostomy education

9.5

44.9

101

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

4.8

44.4

155

336

U07

ICPC

Urine symptom/complaint other

2.9

44.1

284

1019

A28

ICPC

Limited function/disability NOS

2.0

44.0

646

3514

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

3.0

44.0

273

956

L02BX03

ATC

abiraterone; oral

10.7

43.8

N13.4

ICD-10 Finland

Hydroureter

+∞

43.8

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

3.3

42.8

233

745

N17.0

ICD-10 Finland

Acute renal failure with tubular necrosis

+∞

42.8

ZXE30

NOMESCO Finland

More than five and less than seven hours

3.0

42.6

268

948

UJF32

NOMESCO Finland

Coloscopy

1.7

42.2

1028

6639

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.4

41.9

370

1597

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

3.7

41.8

194

548

KH1LA

NOMESCO Finland

Kinetic X-ray examination of urinary tract with pictures

22.1

41.8

D64.9

ICD-10 Finland

Anaemia, unspecified

2.2

41.6

445

2109

JAL30

NOMESCO Finland

Omentectomy

7.6

41.4

133

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

6.4

41.4

111

176

JN4CD

NOMESCO Finland

Very extensive body CT

3.3

41.0

219

691

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.2

41.0

438

2076

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

2.4

40.8

390

1749

R11

ICD-10 Finland

Nausea and vomiting

2.5

40.8

346

1461

B05DA

ATC

Isotonic solutions

39.7

40.6

JFB00

NOMESCO Finland

Partial resection of small intestine

5.8

40.5

118

208

L02AE02

ATC

leuprorelin; implant, parenteral

2.7

40.2

290

1116

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.1

39.6

228

759

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

5.9

39.2

112

193

204

Kela drug reimbursment

Leukemia lymphatica

4.0

39.2

165

429

JFF10

NOMESCO Finland

Loop enterostomy

14.6

39.0

KBD00

NOMESCO Finland

Partial excision of ureter

106.0

38.8

Z49.2

ICD-10 Finland

Other dialysis

51.6

38.6

Z3231

NOMESCO Finland

Registered nurse

1.7

38.4

1078

7220

A06AH03

ATC

naloxegol; oral

7.4

38.3

128

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

2.8

38.2

267

1009

L02BB04

ATC

enzalutamide; oral

6.9

38.1

143

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

4.1

38.1

153

381

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.0

38.0

572

3128

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

4.5

38.0

138

312

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

19.0

37.9

N28.8

ICD-10 Finland

Other specified disorders of kidney and ureter

26.3

37.6

KCD32

NOMESCO Finland

Cystoscopic destruction of tumour of bladder

7.9

37.5

112

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

3.5

37.2

180

526

C08CA01

ATC

amlodipine; oral

1.6

36.8

1378

9924

Q62.0

ICD-10 Finland

Congenital hydronephrosis

101.0

36.8

TK810

NOMESCO Finland

Hemofiltration

38.8

36.5

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.3

36.1

352

1595

352

Kela drug reimbursment

Abiraterone and enzalutamide

7.3

35.9

123

N99.5

ICD-10 Finland

Malfunction of external stoma of urinary tract

127.8

35.7

SPAT1254

SPAT

Administration of medicine

1.9

35.2

588

3333

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

7.1

35.2

127

A06AD11

ATC

lactulose; oral

1.9

35.0

606

3477

KBH62

NOMESCO Finland

Transluminal endoscopic dilatation of ureter

181.5

34.8

P01AB01

ATC

metronidazole; oral, rectal

1.6

34.6

1409

10322

A04AD12

ATC

aprepitant; systemic

4.7

34.5

120

260

SPAT1263

SPAT

Sampling

1.5

34.5

1607

12144

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

4.7

34.1

120

263

KAC20

NOMESCO Finland

Nephroureterectomy

42.4

34.0

8120/3-C66.9

ICD-O-3

Transitional cell carcinoma, NOS, of ureter

339.8

34.0

E87.5

ICD-10 Finland

Hyperkalaemia

7.0

33.9

123

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

4.8

33.9

117

251

V03AE03

ATC

lanthanum carbonate; oral

176.4

33.8

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.2

32.9

348

1638

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

4.2

32.8

128

311

U13

ICPC

Bladder symptom/complaint other

3.6

32.8

156

451

Z43.6

ICD-10 Finland

Attention to other artificial openings of urinary tract

171.3

32.7

5920A

ICD-9 Finland

Calculus of kidney and ureter, Calculus of kidney

18.7

32.6

B03XA01

ATC

erythropoietin; parenteral

10.8

32.6

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

5.0

32.4

106

215

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

32.3

582

3379

N13.6

ICD-10 Finland

Pyonephrosis

+∞

32.3

ZX136

NOMESCO Finland

Intravesicalis

8.0

32.2

WX320

NOMESCO Finland

Spinalanesthesy

1.7

32.2

879

5795

KH1EE

NOMESCO Finland

Urologic ultrasound examination

19.4

31.7

JAH01

NOMESCO Finland

Laparoscopy

2.9

31.7

200

709

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

2.2

31.5

341

1619

KH1CB

NOMESCO Finland

Urography with X-ray

27.1

31.5

U06

ICPC

Haematuria

3.7

31.5

142

393

A04AA55

ATC

palonosetron, combinations; systemic

3.6

31.4

147

419

H05BX01

ATC

cinacalcet; oral

17.7

31.4

K56.7

ICD-10 Finland

Ileus, unspecified

4.9

31.3

104

215

B05DB

ATC

Hypertonic solutions

39.4

31.2

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.5

30.6

258

1083

L04AD01

ATC

ciclosporin; systemic

5.6

30.5

166

L03AA02

ATC

filgrastim; parenteral

3.5

30.5

148

435

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

7.4

30.3

100

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

6.7

30.3

118

59000

ICD-8 Finland

Infections of kidney, Pyelonephritis chronica

+∞

30.2

LAF10

NOMESCO Finland

Bilateral salpingo-oophorectomy

3.4

30.2

149

444

G04AC01

ATC

3.6

29.9

141

405

N35.9

ICD-10 Finland

Urethral stricture, unspecified

5.6

29.8

159

N18

ICD-10 Finland

Chronic kidney disease

11.6

29.5

KH1DD

NOMESCO Finland

CT urography of urinary organs

30.3

29.4

KCE02

NOMESCO Finland

Transluminal endoscopic extraction of calculus from bladder

7.2

29.3

102

KCW96

NOMESCO Finland

Other operations on bladder

8.2

29.2

N13.7

ICD-10 Finland

Vesicoureteral-reflux-associated uropathy

+∞

29.2

KAC00

NOMESCO Finland

Nephrectomy

15.8

28.9

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.6

28.9

1058

7485

Z43.5

ICD-10 Finland

Attention to cystostomy

11.9

28.9

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

25.2

28.7

WX892

NOMESCO Finland

Monitored bed care

2.2

28.7

305

1437

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.7

28.5

201

761

KDV12

NOMESCO Finland

Urethroscopic internal urethrotomy

6.1

28.5

132

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

28.2

914

6271

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

5.7

28.1

146

ZX070

NOMESCO Finland

Intensity modified radiotherapy

3.7

28.1

127

353

C56.71

ICD-10 Finland

Serous epithelial malignant tumor of the ovary

7.1

27.8

JAL20

NOMESCO Finland

Excision or destruction of lesion of peritoneum

11.4

27.8

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

33.0

27.7

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.6

27.6

763

5022

JEA00

NOMESCO Finland

Appendectomy

2.3

27.4

255

1126

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

3.7

27.3

124

346

C07AB07

ATC

bisoprolol; oral

1.4

27.1

1799

14401

N11.9

ICD-10 Finland

Chronic tubulo-interstitial nephritis, unspecified

+∞

27.1

ZXD10

NOMESCO Finland

Scheduled procedure

1.5

27.0

1447

11099

KC1GB

NOMESCO Finland

Cystography with X-ray

5.5

26.9

150

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.7

26.9

192

734

M04AA01

ATC

allopurinol; systemic

1.8

26.9

503

2946

C67.0

ICD-10 Finland

Malignant neoplasm: Trigone of bladder

12.8

26.6

J01XE01

ATC

nitrofurantoin; oral

4.3

26.5

232

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

7.7

26.5

L03AA14

ATC

lipegfilgrastim; parenteral

4.1

26.4

104

256

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

5.6

26.3

142

R18

ICD-10 Finland

Ascites

4.4

26.2

225

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.4

26.1

235

1019

R4110

NOMESCO Finland

Physiotherapy

1.5

26.0

956

6745

C56.00

ICD-10 Finland

Malignant tumor of the ovary without histology

10.3

25.9

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.1

25.8

299

1462

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

5.1

25.8

162

TKD00

NOMESCO Finland

Dilatation of urethra

6.5

25.6

104

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.4

25.5

228

986

N39.9

ICD-10 Finland

Disorder of urinary system, unspecified

4.7

25.4

187

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

50.3

25.2

Y77

ICPC

Malignant neoplasm prostate

2.7

25.1

175

662

U76

ICPC

Malignant neoplasm of bladder

18.2

24.8

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

2.0

24.7

357

1909

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

4.2

24.6

235

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.7

24.4

580

3651

KCV22

NOMESCO Finland

Transluminal endoscopic evacuation of blood clots from bladder

22.0

24.3

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

9.0

24.2

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

3.6

24.2

110

308

WX002

NOMESCO Finland

Sedation and analgesia

1.6

24.1

734

4934

J01MA01

ATC

ofloxacin; systemic

1.9

24.1

356

1916

U08

ICPC

Urinary retention

3.9

24.1

100

259

D70.82

ICD-10 Finland

Drug-induced neutropenia

4.5

24.0

198

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

+∞

24.0

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

9.9

23.9

N03AX16

ATC

pregabalin; oral

1.6

23.8

805

5550

K65.0

ICD-10 Finland

Acute peritonitis

5.6

23.8

127

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

2.8

23.8

157

573

JN2DG

NOMESCO Finland

Very extensive MRI examination of lower part of abdoment with high intensity magnet

6.2

23.7

104

KCC30

NOMESCO Finland

Cystectomy with excision of female internal genital organs

41.6

23.6

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

3.4

23.4

116

348

SPAT1168

SPAT

Catheterisation training

8.4

23.3

R4190

NOMESCO Finland

Nutritional therapy

3.0

23.2

135

455

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

4.5

23.2

187

Q62.7

ICD-10 Finland

Congenital vesico-uretero-renal reflux

54.3

23.0

C65

ICD-10 Finland

Malignant neoplasm of renal pelvis

14.0

23.0

N40

ICD-10 Finland

Hyperplasia of prostate

1.5

22.9

909

6496

5911A

ICD-9 Finland

Hydronephrosis[HYDROURETERONEPHROSIS]

+∞

22.9

JFF23

NOMESCO Finland

Transversostomy

5.3

22.9

133

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

3.9

22.8

252

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.6

22.8

605

3921

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

4.7

22.7

169

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

231.1

22.6

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.2

22.6

238

1114

U71

ICPC

Cystitis/urinary infection other

2.3

22.5

217

975

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.4

22.4

197

845

TK820

NOMESCO Finland

Peritoneal dialysis

32.4

22.4

LCD00

NOMESCO Finland

Hysterectomy

2.6

22.3

171

680

N30

ICD-10 Finland

Cystitis

2.1

22.3

252

1217

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

6.6

22.2

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

5.9

22.0

107

K59.09

ICD-10 Finland

Constipation, unspecified

2.2

22.0

241

1151

Z93.3

ICD-10 Finland

Colostomy status

6.7

21.9

KA9AE

NOMESCO Finland

Ultrasound examination transplanted kidney

+∞

21.9

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

+∞

21.9

KBH21

NOMESCO Finland

Percutaneous endoscopic replantation of ureter

+∞

21.9

59330

ICD-8 Finland

Other diseases of kidney and ureter, Obstruction of ureter, not elsewhere classified

+∞

21.9

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

21.8

1740

14204

SPAT1109

SPAT

Analgesia with portable analgesic pump

8.0

21.7

ZX112

NOMESCO Finland

Subcutaneous

3.3

21.6

109

332

L02BX02

ATC

degarelix; parenteral

4.4

21.4

179

ZXA00

NOMESCO Finland

Right side

1.5

21.4

993

7320

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.2

21.2

231

1100

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.6

21.1

548

3523

GD1AD

NOMESCO Finland

Thorax CT examination

2.5

21.1

170

697

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

4.2

21.0

192

KBH96

NOMESCO Finland

Other repair or connection of ureter

+∞

20.8

KAH62

NOMESCO Finland

Endopyelotomy

77.2

20.7

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

5.4

20.6

116

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

6.1

20.5

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.1

20.2

242

1198

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

20.2

1516

12197

D41.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Renal pelvis

11.7

20.2

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

20.2

2148

18308

Z2446

NOMESCO Finland

Social worker

2.1

20.1

237

1167

N30.2

ICD-10 Finland

Other chronic cystitis

6.2

20.1

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

3.7

20.0

236

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

6.0

19.9

JN2AE

NOMESCO Finland

Ultrasound examination of lower part of abdomen without contrast

5.3

19.9

117

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.9

19.9

120

415

C77.5

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrapelvic lymph nodes

12.6

19.8

Q62.18

ICD-10 Finland

Other specified atresia and stenosis of ureter

+∞

19.8

5937A

ICD-9 Finland

Other disorders of kidney and ureter, Vesicoureteric reflux

+∞

19.8

KAH30

NOMESCO Finland

Pyeloureteroplasty without division of ureteropelvic junction

+∞

19.8

KBH50

NOMESCO Finland

Ureterolysis

+∞

19.8

L28

ICPC

Limited function/disability (L)

1.6

19.7

550

3598

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

73.8

19.7

E86

ICD-10 Finland

Volume depletion

3.5

19.6

266

7532A

ICD-9 Finland

Congenital anomalies of urinary system, Obstructive defects of renal pelvis and ureter

200.8

19.6

KAE01

NOMESCO Finland

Nephroscopic nephrolithotomy

40.3

19.5

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

4.1

19.4

188

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.3

19.4

175

764

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

19.3

758

5377

5921A

ICD-9 Finland

Calculus of kidney and ureter, Calculus of ureter

4.2

19.2

176

R53

ICD-10 Finland

Malaise and fatigue

1.5

19.1

685

4761

205

Kela drug reimbursment

Chronic hypertension

1.4

19.1

1050

7974

D48.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Retroperitoneum

14.0

19.0

PJD44

NOMESCO Finland

Excision of iliac lymph nodes

5.6

19.0

SPAT1301

SPAT

No procedures

1.4

18.9

1145

8848

KCC00

NOMESCO Finland

Cystectomy

55.2

18.9

KDE20

NOMESCO Finland

Removal of foreign body from urethra

5.6

18.8

100

JN3DG

NOMESCO Finland

Very extensive MRI examination with high intensity magnet

9.1

18.8

N15.1

ICD-10 Finland

Renal and perinephric abscess

+∞

18.8

XJH00

NOMESCO Finland

Transanal ultrasonography

1.9

18.7

286

1559

N11.1

ICD-10 Finland

Chronic obstructive pyelonephritis

190.8

18.5

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.9

18.5

269

1439

A79

ICPC

Malignancy NOS

3.8

18.4

203

N99.1

ICD-10 Finland

Postprocedural urethral stricture

6.4

18.3

JN2BG

NOMESCO Finland

MRI examination of lower part of abdoment with high intensity magnet

7.2

18.2

ZXA05

NOMESCO Finland

Left side

1.4

18.2

921

6872

T83.0

ICD-10 Finland

Mechanical complication of urinary (indwelling) catheter

17.6

18.2

321

Kela drug reimbursment

Paricalcitol and cinacalcet

11.0

18.2

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

6.9

18.2

JN2CG

NOMESCO Finland

Extensive MRI examination of lower part of abdoment with high intensity magnet

3.7

18.0

222

L02AE03

ATC

goserelin; implant

3.8

18.0

202

B37.7

ICD-10 Finland

Candidal sepsis

33.0

17.9

XX9LA

NOMESCO Finland

Complementary kinetic X-ray examination without contrast

6.5

17.9

C56

ICD-10 Finland

Malignant neoplasm of ovary

8.7

17.9

WF001

NOMESCO Finland

Preoperative radiotherapy

4.7

17.9

128

KCF02

NOMESCO Finland

Transluminal endoscopic removal of foreign body from bladder

22.8

17.7

R06.0

ICD-10 Finland

Dyspnoea

1.4

17.7

851

6284

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.4

17.6

155

668

C20

ICD-10 Finland

Malignant neoplasm of rectum

5.6

17.6

N26

ICD-10 Finland

Unspecified contracted kidney

36.8

17.6

75329

ICD-8 Finland

Congenital anomalies of urinary system, Hydronephrosis alia sive hydroureter alius sive NUD

95.4

17.6

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.9

17.5

263

1425

I50.9

ICD-10 Finland

Heart failure, unspecified

1.6

17.5

474

3078

WC105

NOMESCO Finland

Simple cytostatic therapy of local tumor recidive

8.0

17.5

LAF16

NOMESCO Finland

Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer

6.5

17.4

7124

FHL

Nephrectomy (simple

28.9

17.4

XX4AT

NOMESCO Finland

Other canalization with ultrasound guidance

9.5

17.3

TKW99

NOMESCO Finland

Other minor surgical procedure in urology

4.8

17.3

119

M10.3

ICD-10 Finland

Gout due to impairment of renal function

13.9

17.2

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.8

17.1

324

1896

XF600

NOMESCO Finland

Bloodpressure measurement

2.0

17.1

232

1209

C67

ICD-10 Finland

Malignant neoplasm of bladder

14.8

17.1

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

4.2

16.9

154

I12.0

ICD-10 Finland

Hypertensive renal disease with renal failure

9.5

16.9

WX110

NOMESCO Finland

Local anesthesy

1.3

16.8

2385

20967

L01BC59

ATC

trifluridine, combinations; systemic

14.1

16.8

SPAT1211

SPAT

Application of soft bandage

1.8

16.7

315

1840

A12AA12

ATC

[U] calcium acetate anhydrous; systemic

63.6

16.7

59358

ICD-8 Finland

Other diseases of kidney and ureter, Morbi ureteris alii

+∞

16.7

N11.8

ICD-10 Finland

Other chronic tubulo-interstitial nephritis

+∞

16.7

Z93

ICD-10 Finland

Artificial opening status

10.4

16.6

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

15.1

16.6

H02AB06

ATC

prednisolone; systemic

1.3

16.6

1639

13652

UKB12

NOMESCO Finland

Retrograde endoscopy of cutaneous ureteroenterostomy

90.4

16.6

JFB30

NOMESCO Finland

Right hemicolectomy

3.5

16.6

217

WX725

NOMESCO Finland

Noninvasive ventilation

2.2

16.6

166

761

ZST00

NOMESCO Finland

Procedure related to previous procedure classified in chapter T

170.6

16.5

KBJ80

NOMESCO Finland

Operation for malfunction of urinary diversion

170.6

16.5

D39.10

ICD-10 Finland

Tumor of uncertain or unknown nature in the ovary without histology

3.1

16.5

304

WVC10

NOMESCO Finland

Subcutaneous infusion of drugs

10.8

16.4

N21.1

ICD-10 Finland

Calculus in urethra

10.8

16.4

KAC21

NOMESCO Finland

Percutaneous endoscopic nephroureterectomy

23.1

16.4

JGB03

NOMESCO Finland

Partial proctectomy with partial excision of mesorectum

10.1

16.4

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

3.3

16.2

258

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.6

16.2

506

3402

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

3.9

16.0

168

KCB00

NOMESCO Finland

Biopsy of bladder

8.6

15.9

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.8

15.9

302

1770

RS220

NOMESCO Finland

4.6

15.9

122

A02BC01

ATC

omeprazole; systemic

1.4

15.8

975

7516

8130/2-C67.9

ICD-O-3

Papillary urothelial carcinoma, non-invasive of bladder, NOS

5.4

15.8

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

12.2

15.8

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

4.9

15.8

105

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.9

15.8

243

1330

WX882

NOMESCO Finland

High dependency care

2.7

15.7

106

395

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.5

15.6

623

4417

5933A

ICD-9 Finland

Other disorders of kidney and ureter, Stricture or kinking of ureter

+∞

15.6

B02AA02

ATC

tranexamic acid; systemic

1.6

15.6

441

2889

KBV04

NOMESCO Finland

Laparoscopic insertion of stent into ureter

160.5

15.5

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

4.4

15.4

130

R93.4

ICD-10 Finland

Abnormal findings on diagnostic imaging of urinary organs

6.2

15.4

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

3.3

15.3

231

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

2.7

15.3

108

414

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.8

15.3

258

1457

ZXE40

NOMESCO Finland

More than seven and less than nine hours

2.7

15.2

102

378

KAC11

NOMESCO Finland

Total nephrectomy with capsule, transcutaneous

5.5

15.2

A10BH05

ATC

linagliptin; oral

2.2

15.2

155

719

WC125

NOMESCO Finland

Demanding cytostatic therapy of local tumor recidive

10.4

15.2

TPX15

NOMESCO Finland

Removal of vascular injection port

10.4

15.2

J01MA14

ATC

moxifloxacin; systemic

1.7

15.2

301

1790

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

2.6

15.1

110

429

KAC10

NOMESCO Finland

Total nephrectomy with capsule

5.2

15.1

7179

FHL

Other measure in this category

20.1

15.1

8461/3-C56.9

ICD-O-3

High grade serous carcinoma of ovary

7.8

15.0

XF400

NOMESCO Finland

ECG with 12 standard connections

1.5

15.0

582

4103

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.9

14.9

318

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.8

14.9

169

Z3226

NOMESCO Finland

Physiotherapist

1.5

14.8

618

4421

KBB00

NOMESCO Finland

Biopsy of ureter

31.8

14.8

WX306

NOMESCO Finland

Lumbar epidural anesthesy

2.0

14.8

201

1050

N25.0

ICD-10 Finland

Renal osteodystrophy

56.9

14.8

JN3CG

NOMESCO Finland

Extensive MRI examination of abdomen with high intensity magnet

7.9

14.8

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

1.9

14.7

227

1242

3018

Kela drug reimbursment

The combination of trifluridine and tipiracil

13.2

14.7

JGB10

NOMESCO Finland

Partial proctectomy and end colostomy

13.2

14.7

KB1DG

NOMESCO Finland

Very extensive MRI of urinary tract

+∞

14.6

N18.4

ICD-10 Finland

Chronic kidney disease, stage 4

+∞

14.6

H05BX02

ATC

paricalcitol; systemic

+∞

14.6

I80.1

ICD-10 Finland

Phlebitis and thrombophlebitis of femoral vein

3.7

14.6

172

JGB30

NOMESCO Finland

Abdominoperineal excision of rectum

7.7

14.6

KF8AE

NOMESCO Finland

Ultrasound examination of scrotum

2.9

14.5

303

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.4

14.5

881

6761

LX1XE

NOMESCO Finland

Other gynecological ultrasound examination

2.6

14.5

107

423

R39.1

ICD-10 Finland

Other difficulties with micturition

2.4

14.4

117

486

C79.6

ICD-10 Finland

Secondary malignant neoplasm of ovary

36.1

14.4

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

3.9

14.4

149

R10.0

ICD-10 Finland

Acute abdomen

2.6

14.4

107

424

N28.9

ICD-10 Finland

Disorder of kidney and ureter, unspecified

9.4

14.4

B01AB04

ATC

dalteparin; parenteral

2.0

14.4

179

904

KK1XE

NOMESCO Finland

Other ultrasound examination of retroperitoneal space and genito-urinary tract

15.4

14.4

1506

Kela drug reimbursment

The combination of trifluridine and tipiracil

12.6

14.3

WX702

NOMESCO Finland

Supraglottic ventilation device

2.1

14.2

171

850

E87.2

ICD-10 Finland

Acidosis

8.2

14.2

1XC07

NOMESCO Finland

10.4

14.2

C56.98

ICD-10 Finland

Malignant tumor of the ovary, indeterminate histology

9.7

14.2

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

3.3

14.0

220

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.2

14.0

139

637

WW200

NOMESCO Finland

Immunization

2.7

14.0

355

WX610

NOMESCO Finland

Patient controlled analgesia

6.6

14.0

NK6AN

NOMESCO Finland

Total body bone isotope imaging

2.3

14.0

130

576

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

1.9

13.9

202

1083

R60.0

ICD-10 Finland

Localized oedema

1.6

13.8

353

2252

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.0

13.8

168

842

C53.01

ICD-10 Finland

Squamous cell carcinoma of the endocervix

23.8

13.8

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

4.5

13.8

108

U04

ICPC

Incontinence urine

2.1

13.7

161

794

KDV10

NOMESCO Finland

Internal urethrotomy

3.4

13.7

192

PJD53

NOMESCO Finland

Block dissection of aortic lymph nodes

8.6

13.7

D62

ICD-10 Finland

Acute posthaemorrhagic anaemia

4.4

13.7

113

L04AX01

ATC

azathioprine; systemic

2.2

13.6

141

659

C20.99

ICD-10 Finland

Malignant tumor of the rectum other or unspecified histology

5.2

13.6

176

Kela drug reimbursment

Regorafenib

12.1

13.6

T86.1

ICD-10 Finland

Kidney transplant failure and rejection

+∞

13.5

V03AE04

ATC

calcium acetate and magnesium carbonate; systemic

+∞

13.5

A07AA09

ATC

vancomycin; oral

3.7

13.5

158

N80.4

ICD-10 Finland

Endometriosis of rectovaginal septum and vagina

4.6

13.5

101

N28.1

ICD-10 Finland

Cyst of kidney

3.3

13.5

205

KBV32

NOMESCO Finland

Cystoscopic incision of ureteric orifice

34.1

13.5

O26.84

ICD-10 Finland

Renal disease pregnancy-related

34.1

13.5

U02

ICPC

Urinary frequency/urgency

1.6

13.4

405

2692

U95

ICPC

Urinary calculus

18.3

13.3

C02AC05

ATC

moxonidine; oral

2.1

13.3

144

686

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

13.3

1186

9648

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.9

13.3

183

962

369

Kela drug reimbursment

Regorafenib

13.8

13.2

Q61.2

ICD-10 Finland

Polycystic kidney, autosomal dominant

13.8

13.2

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

3.5

13.2

177

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.1

13.2

148

718

WX400

NOMESCO Finland

Inhalation anesthesy

2.1

13.1

145

698

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

2.9

13.1

265

N45.9

ICD-10 Finland

Orchitis, epididymitis and epididymo-orchitis without abscess

2.7

13.1

317

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.8

13.1

224

1272

Z93.5

ICD-10 Finland

Cystostomy status

12.2

13.1

WX224

NOMESCO Finland

Blockade of obturius nerve

15.1

13.1

S18

ICPC

Laceration/cut

1.3

13.1

1438

12043

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

1.9

13.0

191

1026

WX704

NOMESCO Finland

Intubation

1.8

12.9

237

1376

SPAT1245

SPAT

Provision of support and information to patient’s family members

2.0

12.9

167

857

KH1ZT

NOMESCO Finland

Removal of stone or foreign body from uringary tract with radiological guidance

50.1

12.8

ZX121

NOMESCO Finland

Central venous catheter

6.9

12.8

E87.6

ICD-10 Finland

Hypokalaemia

2.4

12.8

106

447

B03BA03

ATC

hydroxocobalamin; parenteral

1.8

12.7

208

1162

K63.1

ICD-10 Finland

Perforation of intestine (nontraumatic)

4.4

12.7

103

C57.9

ICD-10 Finland

Malignant neoplasm: Female genital organ, unspecified

9.0

12.7

Z93.2

ICD-10 Finland

Ileostomy status

9.7

12.7

J01XX05

ATC

methenamine; oral

4.7

12.7

SPAT1088

SPAT

Blood transfusion

5.8

12.7

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

12.6

904

7101

5934A

ICD-9 Finland

Other disorders of kidney and ureter, Other ureteric obstruction

+∞

12.5

J01CA04

ATC

amoxicillin; systemic

1.3

12.5

2883

26481

JA3BT

NOMESCO Finland

Cathetrisation of abdominal cavity with X-ray guidance

8.7

12.5

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

2.4

12.4

106

452

5AB14

NOMESCO Finland

20.1

12.4

Q64.2

ICD-10 Finland

Congenital posterior urethral valves

130.3

12.4

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.3

12.4

118

532

JFB46

NOMESCO Finland

Resection of sigmoid colon

3.4

12.4

170

N05CF01

ATC

zopiclone; oral

1.3

12.4

1103

8951

SPAT1229

SPAT

Assessment of need for aid

1.7

12.4

263

1595

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.5

12.3

399

A10AE04

ATC

insulin glargine; parenteral

1.7

12.2

278

1717

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

2.7

12.2

301

G04BD08

ATC

solifenacin; oral

1.7

12.2

238

1408

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

2.8

12.2

294

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

5.5

12.2

JFG10

NOMESCO Finland

Closure of loop colostomy without resection

4.2

12.2

108

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

3.1

12.2

211

J01FF01

ATC

clindamycin; systemic

1.3

12.1

860

6746

7151

FHL

Kidney transplantation

26.7

12.0

C54.1

ICD-10 Finland

Malignant neoplasm: Endometrium

8.7

12.0

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

5.7

11.9

PBM10

NOMESCO Finland

Closure of arteriovenous fistula of radial artery

46.8

11.9

ZX095

NOMESCO Finland

Combined chemoradiotherapy

4.8

11.9

JFB33

NOMESCO Finland

Other resection comprising small intestine and colon

14.7

11.8

N31.0

ICD-10 Finland

Uninhibited neuropathic bladder, not elsewhere classified

8.4

11.8

XF612

NOMESCO Finland

Measurement of central venous pressure

8.4

11.8

N23

ICD-10 Finland

Unspecified renal colic

8.4

11.8

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

5.6

11.7

C18.7

ICD-10 Finland

Malignant neoplasm: Sigmoid colon

5.6

11.7

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

11.7

566

4155

U77

ICPC

Malignant neopl urinary tract other

9.6

11.7

R60.9

ICD-10 Finland

Oedema, unspecified

1.9

11.6

160

842

LEB00

NOMESCO Finland

Biopsy of vagina

3.2

11.6

185

KBH45

NOMESCO Finland

Endoureterotomy

65.1

11.6

UKC12

NOMESCO Finland

Retrograde endoscopy of cutaneous cystoenterostomy

65.1

11.6

JKA20

NOMESCO Finland

Cholecystectomy

2.3

11.6

107

477

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.5

11.6

431

3004

H02AB04

ATC

methylprednisolone; systemic

1.5

11.5

455

3215

D638, N180

ICD-10 Finland

+∞

11.5

7187

FHL

Ureterohydroplasty due to reflux, for example

+∞

11.5

PBU84

NOMESCO Finland

Plastic repair of arteriovenous fistula from artery of upper extremity

+∞

11.5

59099

ICD-8 Finland

Infections of kidney, Other

+∞

11.5

ZX080

NOMESCO Finland

Image guided radiotherapy

2.6

11.5

307

JFG00

NOMESCO Finland

Closure of loop enterostomy without resection

5.6

11.4

A09AA02

ATC

multienzymes (lipase, protease etc.)

2.8

11.4

253

SPAT1172

SPAT

Guidance concerning hydration

2.5

11.4

368

C53.02

ICD-10 Finland

Adenocarcinoma of the endocervix

13.6

11.4

KCC20

NOMESCO Finland

Cystoprostatourethrectomy

120.3

11.4

N13

ICD-10 Finland

Obstructive and reflux uropathy

120.3

11.4

KBV22

NOMESCO Finland

Cystoscopic dilatation of ureteric orifice

120.3

11.4

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

11.4

1308

10964

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

4.4

11.4

K43.0

ICD-10 Finland

Incisional hernia with obstruction, without gangrene

4.4

11.4

WVA20

NOMESCO Finland

Medicine administration

2.6

11.3

303

UKD02

NOMESCO Finland

Urethroscopy

6.0

11.3

WF002

NOMESCO Finland

Radical radiotherapy

1.8

11.3

190

1073

WD215

NOMESCO Finland

Multiple therapy of methastized malignancy with hormones

15.0

11.3

N20

ICD-10 Finland

Calculus of kidney and ureter

15.0

11.3

G04CA01

ATC

alfuzosin; oral

1.5

11.3

433

3037

KAS20

NOMESCO Finland

Allogenic transplantation of kidney from living donor

35.1

11.3

I50.0

ICD-10 Finland

Congestive heart failure

1.7

11.2

232

1396

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

2.9

11.2

229

Z46.6

ICD-10 Finland

Fitting and adjustment of urinary device

17.1

11.2

KB1CG

NOMESCO Finland

Extensive MRI examination of urinary tract with high intensity magnet

20.1

11.1

I71.4

ICD-10 Finland

Abdominal aortic aneurysm, without mention of rupture

2.3

11.1

103

461

Z43.2

ICD-10 Finland

Attention to ileostomy

11.2

11.0

UJG02

NOMESCO Finland

Proctoscopy

2.5

11.0

340

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.0

10.9

129

641

N80.3

ICD-10 Finland

Endometriosis of pelvic peritoneum

2.6

10.9

287

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

3.3

10.9

167

WX872

NOMESCO Finland

Intensive care

1.9

10.9

162

879

N05BA04

ATC

oxazepam; oral

1.3

10.9

779

6109

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.9

10.8

111

JFG20

NOMESCO Finland

Closure of enterostomy with resection of exteriorised loop

6.9

10.8

T81.9

ICD-10 Finland

Unspecified complication of procedure

2.8

10.8

253

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.7

10.7

215

1281

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

1.8

10.7

168

926

TKE00

NOMESCO Finland

Needle biopsy of prostate

1.8

10.7

174

973

JFB60

NOMESCO Finland

Resection of sigmoid colon with end colostomy

5.2

10.7

S37.1

ICD-10 Finland

Injury of ureter

21.5

10.7

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.5

10.6

315

WC305

NOMESCO Finland

Simple therapy of local tumor recidive with biomodifiers

6.7

10.6

KAE10

NOMESCO Finland

Pyelolithotomy

60.1

10.6

N80.89

ICD-10 Finland

Endometriosis with other specified or multiple localization

8.0

10.6

YL1CD

NOMESCO Finland

Very extensive CT examination of pelvis for dose design of radiotherapy

8.0

10.6

N30.1

ICD-10 Finland

Interstitial cystitis (chronic)

3.5

10.6

134

JG1CG

NOMESCO Finland

Extensive MRI of rectum

4.9

10.5

LAF00

NOMESCO Finland

Unilateral salpingo-oophorectomy

3.9

10.4

105

ZXC96

NOMESCO Finland

Robot assisted procedure

2.2

10.4

101

460

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

3.6

10.4

125

G63.8*N18.8

ICD-10 Finland

Uraemic neuropathy

110.3

10.4

7105

FHL

Pyelo- or nephrolithotomy

110.3

10.4

Q62.11

ICD-10 Finland

Congenital bilateral occlusion of the pelvic ureteral junction

110.3

10.4

Q60.0

ICD-10 Finland

Renal agenesis, unilateral

+∞

10.4

D638, N189

ICD-10 Finland

+∞

10.4

L04AA01

ATC

[U] ciclosporin; systemic

3.4

10.4

146

WX600

NOMESCO Finland

Single shot through catheter

2.9

10.4

218

ZX090

NOMESCO Finland

Other technic of radiotherapy

2.2

10.4

108

508

59203

ICD-8 Finland

Calculus of kidney and ureter, Calculus ureteris

2.8

10.3

225

N03.9

ICD-10 Finland

Chronic nephritic syndrome, unspecified

16.1

10.3

KBJ60

NOMESCO Finland

Anastomosis of ureter to urethra with interposition of ileum

16.1

10.3

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.3

10.3

758

5957

KBV52

NOMESCO Finland

Cystoscopic injection therapy for vesicourethral reflux

32.6

10.3

KA5AT

NOMESCO Finland

Puncture of kidney cyst with ultrasound guidance

32.6

10.3

E83.50

ICD-10 Finland

Hypercalcemia

3.5

10.3

137

WW200

SPAT

0.6

10.3

123

2136

8140/3-C53.9

ICD-O-3

Adenocarcinoma, NOS, of cervix uteri

18.8

10.2

X77

ICPC

Malignant neopl genital female other

7.1

10.2

L02BA03

ATC

fulvestrant; parenteral

5.7

10.2

Z43.3

ICD-10 Finland

Attention to colostomy

9.6

10.2

N32.1

ICD-10 Finland

Vesicointestinal fistula

9.6

10.2

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

10.2

438

JFF24

NOMESCO Finland

Laparoscopic transversostomy

23.4

10.2

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.6

10.2

290

1899

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

3.5

10.2

133

ZXD40

NOMESCO Finland

Procedure on patient requiring isolation

7.5

10.2

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

4.3

10.2

K59.0

ICD-10 Finland

Constipation

1.7

10.1

189

1105

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

4.7

10.1

KCW98

NOMESCO Finland

Other transluminal endoscopic operation on bladder

11.3

10.0

L01XE21

ATC

[U] regorafenib; oral

11.3

10.0

M10.9

ICD-10 Finland

Gout, unspecified

1.7

10.0

200

1193

C18.11

ICD-10 Finland

Malignant tumor of the appendix invasive carcinoma

8.4

10.0

ZX100

NOMESCO Finland

Oral

2.9

10.0

212

SPAT1216

SPAT

Assessment of functional ability

1.4

10.0

504

3723

NF3AA

NOMESCO Finland

Femur X-ray examination

2.6

10.0

266

D01

ICPC

Abdominal pain/cramps general

1.5

10.0

304

2025

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

4.0

10.0

C67.6

ICD-10 Finland

Malignant neoplasm: Ureteric orifice

40.1

10.0

3025

Kela drug reimbursment

Calcium carbonate

40.1

10.0

PB1BC

NOMESCO Finland

Extensive angiography of upper extremity with X-ray

40.1

10.0

7534X

ICD-9 Finland

Congenital anomalies of urinary system, Other specified anomalies of ureter

40.1

10.0

XKC03

NOMESCO Finland

Water cystometry

2.2

10.0

100

463

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

3.2

9.9

157

GD1UN

NOMESCO Finland

Lung circulation SPECT

5.3

9.9

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.6

9.9

285

192

Kela drug reimbursment

Fulvestrant

5.8

9.9

D64.8

ICD-10 Finland

Other specified anaemias

3.0

9.9

186

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.9

9.8

151

829

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

1.9

9.8

131

684

KCJ00

NOMESCO Finland

Cystostomy

26.1

9.8

KC1AE

NOMESCO Finland

Percutaneous ultrasound examination of urinary bladder

10.6

9.8

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

9.7

917

7461

JG1BG

NOMESCO Finland

MRI of rectum

4.2

9.7

SPAT1153

SPAT

Removal of sutures

1.3

9.7

1080

8985

6112

FHL

Installation of a peritoneal dialysis or lavage catheter in an operating room

55.1

9.6

KAE11

NOMESCO Finland

Nephroscopic pyelolithotomy

55.1

9.6

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.5

9.6

379

2671

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

5.8

9.6

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

2.3

9.6

353

L02AB02

ATC

medroxyprogesterone; systemic (progestogens)

4.7

9.6

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.5

9.6

308

KBE22

NOMESCO Finland

Transluminal endoscopic dislodgement of impacted calculus from ureter

11.4

9.5

R82.8

ICD-10 Finland

Abnormal findings on cytological and histological examination of urine

10.0

9.5

R30.0

ICD-10 Finland

Dysuria

2.0

9.5

114

573

XPX08

NOMESCO Finland

Intraoperative flow measurement

3.9

9.5

Z99.2

ICD-10 Finland

Dependence on renal dialysis

100.2

9.4

Y69

ICD-10 Finland

Unspecified misadventure during surgical and medical care

3.3

9.4

142

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

2.7

9.4

227

C53.00

ICD-10 Finland

Malignant tumor of endocervix without histology

30.1

9.4

Z90.5

ICD-10 Finland

Acquired absence of kidney

30.1

9.4

WX199

NOMESCO Finland

Other local analgesia

2.2

9.4

415

O23.0

ICD-10 Finland

Infections of kidney in pregnancy

17.5

9.4

Q62.3

ICD-10 Finland

Other obstructive defects of renal pelvis and ureter

+∞

9.4

D638, N188

ICD-10 Finland

+∞

9.4

5900A

ICD-9 Finland

Infections of kidney, Chronic pyelonephritis

+∞

9.4

S97

ICPC

Chronic ulcer skin

1.8

9.4

166

957

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.5

9.4

322

2208

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.8

9.4

166

958

KAC01

NOMESCO Finland

Percutaneous endoscopic nephrectomy

12.3

9.3

KCV02

NOMESCO Finland

Cystoscopic balloon distension of bladder

21.7

9.3

C79.1

ICD-10 Finland

Secondary malignant neoplasm of bladder and other and unspecified urinary organs

21.7

9.3

ZXH04

NOMESCO Finland

Procedure performed in other inpatient unit

6.9

9.3

N17

ICD-10 Finland

Acute renal failure

10.7

9.3

JGB00

NOMESCO Finland

Partial proctectomy and colorectal or coloanal anastomosis

4.3

9.3

A03

ICPC

Fever

1.4

9.2

432

3151

N30.8

ICD-10 Finland

Other cystitis

4.6

9.2

C08CA02

ATC

felodipine; oral

1.5

9.2

302

2050

8120/2-C67.9

ICD-O-3

Urothelial carcinoma in situ of bladder, NOS

13.7

9.2

C10AC01

ATC

colestyramine; oral

2.2

9.1

383

H3603, E103

ICD-10 Finland

4.1

9.1

AA1AD

NOMESCO Finland

CT of head and brain

1.3

9.1

768

6152

C82.1

ICD-10 Finland

Follicular lymphoma grade II

4.6

9.1

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

9.0

389

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.4

9.0

440

3232

RD210

NOMESCO Finland

2.8

9.0

198

KC1GD

NOMESCO Finland

CT cystography of bladder

36.7

9.0

X75

ICPC

Malignant neoplasm cervix

36.7

9.0

C67.4

ICD-10 Finland

Malignant neoplasm: Posterior wall of bladder

9.0

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.5

9.0

300

2041

Z51.88

ICD-10 Finland

Other specified medical care

2.5

9.0

275

NF1AA

NOMESCO Finland

Hip X-ray examination

1.5

9.0

273

1820

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

7.4

8.9

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

7.4

8.9

U79

ICPC

Neoplasm urinary tract unspecified

24.0

8.9

A40.8

ICD-10 Finland

Other streptococcal sepsis

3.6

8.9

106

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

3.3

8.9

127

KKB10

NOMESCO Finland

Excision of retroperitoneal tumour

12.5

8.9

8070/3-C53.9

ICD-O-3

Squamous cell carcinoma, NOS, of cervix uteri

12.5

8.9

178

Kela drug reimbursment

Combination product containing tegafur, gimeracil and oteracil

12.5

8.9

SPAT1269

SPAT

Other puncture and/or drainage

3.9

8.8

XW3AT

NOMESCO Finland

Biopsy of other superficial organ with ultrasound guidance

5.3

8.7

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.0

8.7

103

513

TPH05

NOMESCO Finland

Open cannulation of peripheral vein

3.5

8.7

108

KED33

NOMESCO Finland

Transurethral incision of prostate

2.6

8.7

249

D99

ICPC

Disease digestive system other

3.3

8.7

124

A46

ICD-10 Finland

Erysipelas

1.4

8.7

422

3098

SPAT1078

SPAT

Removal of central venous or arterial cannula

14.0

8.7

Q62.5

ICD-10 Finland

Duplication of ureter

50.1

8.7

PG5AC

NOMESCO Finland

Contrast examination of injection gate to artery or vein

50.1

8.7

C09AA02

ATC

enalapril; systemic

1.3

8.7

667

5271

C08CA03

ATC

isradipine; systemic

3.0

8.6

152

D06

ICPC

Abdominal pain localized other

1.6

8.6

239

1557

PG1XE

NOMESCO Finland

Other ultrasound examination of blood vessel not elsewhere classified

5.0

8.6

O99.89

ICD-10 Finland

Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium

3.0

8.6

158

1520

FHL

Ureteropyeloscopy

8.2

8.6

C18.1

ICD-10 Finland

Malignant neoplasm: Appendix

11.6

8.6

N05BA06

ATC

lorazepam; systemic, sublingual

1.7

8.6

157

917

5990B

ICD-9 Finland

Other disorders of urethra and urinary tract, Urinary tract infection, site not specified[INFECTIO VIARUM URINARIUM ACUTA]

4.2

8.5

KCE00

NOMESCO Finland

Cystolithotomy

16.3

8.5

N80.1

ICD-10 Finland

Endometriosis of ovary

2.4

8.5

298

U01

ICPC

Dysuria/painful urination

1.6

8.5

199

1244

JFC00

NOMESCO Finland

Entero-enterostomy

10.0

8.5

D37.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Rectum

3.5

8.5

105

D41.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Urinary organ, unspecified

20.0

8.5

N02.9

ICD-10 Finland

Recurrent and persistent haematuria, unspecified

20.0

8.5

H26.3

ICD-10 Finland

Drug-induced cataract

5.1

8.4

EBA15

NOMESCO Finland

Extraction of large number of teeth

1.9

8.4

118

629

7538X

ICD-9 Finland

Congenital anomalies of urinary system, Other specified anomalies of bladder and urethra

90.2

8.4

75348

ICD-8 Finland

Congenital anomalies of urinary system, Maleformationes ureteris aliae

90.2

8.4

ZXE60

NOMESCO Finland

More than 12 and less than 15 hours

3.9

8.4

SPAT1249

SPAT

Treatment-related counselling outside office

1.2

8.4

1323

11421

I82.88

ICD-10 Finland

Embolism and thrombosis of other specified veins

2.6

8.4

225

R32

ICD-10 Finland

Unspecified urinary incontinence

2.2

8.4

391

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.6

8.4

232

C18.09

ICD-10 Finland

Malignant tumor of caecum other or unspecified histology

6.7

8.3

Q62.2

ICD-10 Finland

Congenital megaloureter

+∞

8.3

7536A

ICD-9 Finland

Congenital anomalies of urinary system, Atresia and stenosis of urethra and bladder neck[OBSTRUCTIO URETHRAE ET COLLI VESICAE CONGENITA]

+∞

8.3

75360

ICD-8 Finland

Congenital anomalies of urinary system, Valvula urethrae cum hydronephrosi

+∞

8.3

Y88

ICD-10 Finland

Sequelae with surgical and medical care as external cause

3.6

8.3

KH1AE

SPAT

3.8

8.3

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

2.3

8.3

320

N80.9

ICD-10 Finland

Endometriosis, unspecified

3.0

8.3

151

N80.5

ICD-10 Finland

Endometriosis of intestine

5.8

8.3

K83.1

ICD-10 Finland

Obstruction of bile duct

2.9

8.3

167

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.0

8.2

104

534

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.7

8.2

197

C18.79

ICD-10 Finland

Malignant tumor of the sigmoid or other unspecified histology

4.7

8.2

JAP01

NOMESCO Finland

Laparoscopic freeing of adhesions in the peritoneal cavity

2.8

8.2

190

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.0

8.2

459

JFC20

NOMESCO Finland

Other enterocolostomy

14.5

8.2

K91.2

ICD-10 Finland

Postsurgical malabsorption, not elsewhere classified

14.5

8.2

UJF30

NOMESCO Finland

Ileoscopy through colon

1.5

8.2

277

1893

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.0

8.2

500

Z29.0

ICD-10 Finland

Isolation

6.0

8.1

Z2221

NOMESCO Finland

Medical doctor

1.3

8.1

882

7287

C16.9

ICD-10 Finland

Malignant neoplasm: Stomach, unspecified

3.9

8.1

Q63.1

ICD-10 Finland

Lobulated, fused and horseshoe kidney

33.4

8.1

Q61.0

ICD-10 Finland

Congenital single renal cyst

33.4

8.1

C68.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of urinary organs

33.4

8.1

JAL00

NOMESCO Finland

Biopsy of peritoneum

4.4

8.0

D30.3

ICD-10 Finland

Benign neoplasm: Bladder

8.9

8.0

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

2.5

8.0

254

N30.4

ICD-10 Finland

Irradiation cystitis

10.0

8.0

Y0699

ICD-8 Finland

Examination of the urinary and genital organs, Urinary organs. Does not include urine tests to determine endocrine and metabolic disorders (Y 00.99)

3.8

8.0

WX202

NOMESCO Finland

Supraclavicular plexus blockade

2.9

8.0

158

KC1JB

NOMESCO Finland

Miktiocystography with X-ray

22.0

8.0

Z94.9

ICD-10 Finland

Transplanted organ and tissue status, unspecified

22.0

8.0

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

3.4

8.0

111

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

2.4

8.0

256

R52.0

ICD-10 Finland

Acute pain

2.1

8.0

414

G04BD12

ATC

mirabegron; oral

1.4

7.9

322

2284

JGB36

NOMESCO Finland

Wide excision of rectum

13.0

7.9

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

3.2

7.8

118

C77.9

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph node, unspecified

8.4

7.8

H02AB07

ATC

prednisone; oral

1.4

7.8

439

3305

JN2AD

NOMESCO Finland

CT examination of lower part of abdomen

10.8

7.8

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

10.8

7.8

YJ1BD

NOMESCO Finland

Extensive CT examination of abdomen for dose design of radiotherapy

10.8

7.8

Y83.6

ICD-10 Finland

Removal of other organ (partial) (total) as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

6.9

7.8

306

Kela drug reimbursment

Erythropoietin and darbepoetin

6.9

7.8

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

2.4

7.7

274

K56.0

ICD-10 Finland

Paralytic ileus

3.3

7.7

114

C53.81

ICD-10 Finland

Overall squamous cell carcinoma of the cervix uteri

45.0

7.7

KBV01

NOMESCO Finland

Nephroscopic insertion of stent into ureter

45.0

7.7

T81.2

ICD-10 Finland

Accidental puncture and laceration during a procedure, not elsewhere classified

3.1

7.7

131

C09AA05

ATC

ramipril; oral

1.3

7.7

826

6812

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

2.6

7.7

204

I82.9

ICD-10 Finland

Embolism and thrombosis of unspecified vein

2.5

7.7

230

B81

ICPC

Anaemia vit B12/folate deficiency

1.8

7.7

123

688

R35

ICD-10 Finland

Polyuria

1.6

7.6

199

1281

C19

ICD-10 Finland

Malignant neoplasm of rectosigmoid junction

3.8

7.6

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.9

7.6

107

571

SPAT1138

SPAT

Guidance concerning bowel function

2.7

7.6

183

C57.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of female genital organs

8.0

7.6

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

2.5

7.6

225

GD2SN

NOMESCO Finland

Lung ventilation SPECT

4.2

7.6

TJA33

NOMESCO Finland

Percutaneous introduction of peritoneal dialysis catheter

25.0

7.6

LCD30

NOMESCO Finland

Radical hysterectomy

11.8

7.6

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

1.7

7.6

151

905

N03AX12

ATC

gabapentin; oral

1.4

7.6

442

3346

103

Kela drug reimbursment

Diabetes, insulin-treated

1.3

7.6

850

7049

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.5

7.6

221

1461

PB1DE

NOMESCO Finland

Upper extremity arteries ultrasound examination with Doppler method

8.8

7.5

C02CA01

ATC

prazosin; oral

2.4

7.5

253

N04.9

ICD-10 Finland

Nephrotic syndrome, unspecified

10.0

7.5

JAK00

NOMESCO Finland

Laparotomy and drainage of peritoneal cavity

10.0

7.5

XKW99

NOMESCO Finland

Other physiological examination of urinary or male genital system

2.6

7.5

202

K91.4

ICD-10 Finland

Colostomy and enterostomy malfunction

7.1

7.5

ZX040

NOMESCO Finland

Intracavity HDR radiotherapy

7.1

7.5

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

2.5

7.4

229

SPAT1111

SPAT

Planning of analgesia

2.9

7.4

150

KAE00

NOMESCO Finland

Nephrolithotomy

80.2

7.4

7188

FHL

Ureteroneocystostomy

80.2

7.4

K92.1

ICD-10 Finland

Melaena

1.6

7.4

163

1007

N32.0

ICD-10 Finland

Bladder-neck obstruction

2.9

7.4

151

D75

ICPC

Malignant neoplasm colon/rectum

3.6

7.3

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

1.9

7.3

495

UJK02

NOMESCO Finland

ERCP

2.0

7.3

418

S37.0

ICD-10 Finland

Injury of kidney

8.4

7.3

C56.73

ICD-10 Finland

Endomeroid epithelial carcinoma of the ovary

8.4

7.3

WD315

NOMESCO Finland

Multiple therapy of methastized malignancy with biomodifiers

8.4

7.3

RS222

NOMESCO Finland

2.8

7.3

159

A12BA02

ATC

potassium citrate; oral

+∞

7.3

KBF02

NOMESCO Finland

Transluminal endoscopic removal of foreign body from ureter

+∞

7.3

59012

ICD-8 Finland

Infections of kidney, Pyelocystitis

+∞

7.3

KB1BG

NOMESCO Finland

MRI examination of urinary tract with high intensity magnet

+∞

7.3

Q64.1

ICD-10 Finland

Exstrophy of urinary bladder

+∞

7.3

C54.10

ICD-10 Finland

Malignant tumor of endometrium without histology

6.8

7.3

A03DA02

ATC

pitofenone and analgesics; systemic

2.2

7.3

304

N39.1

ICD-10 Finland

Persistent proteinuria, unspecified

4.5

7.2

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.6

7.2

190

1227

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.3

7.2

547

4306

D20.0

ICD-10 Finland

Benign neoplasm: Retroperitoneum

15.8

7.2

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

1.7

7.2

136

804

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.3

7.2

729

5964

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

3.2

7.2

110

JFF13

NOMESCO Finland

Terminal enterostomy

7.3

7.2

A04

ICPC

Weakness/tiredness general

1.4

7.2

379

2821

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

2.1

7.2

343

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

2.6

7.2

185

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.6

7.1

196

XX9AN

NOMESCO Finland

Complementary isotope examination or additional picture

6.6

7.1

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

1.9

7.1

501

JF2AB

NOMESCO Finland

Colongraphy with X-ray

5.0

7.1

T83.1

ICD-10 Finland

Mechanical complication of other urinary devices and implants

12.0

7.1

KWA00

NOMESCO Finland

Repair of wound dehiscence in urological surgery

12.0

7.1

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.4

7.1

253

8140/3-C19.9

ICD-O-3

Adenocarcinoma, NOS, of rectosigmoid junction

5.3

7.1

QBG30

NOMESCO Finland

Delayed skin closure of surgical wound in trunk

8.8

7.0

ZXE70

NOMESCO Finland

Moren than 15 and less than 18 hours

8.8

7.0

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

3.1

7.0

112

J01CF05

ATC

flucloxacillin; systemic

1.8

7.0

108

597

JFK10

NOMESCO Finland

Freeing of adhesions in intestinal obstruction

4.7

7.0

SPAT1290

SPAT

Preparation of deceased person

7.0

Z01.8

ICD-10 Finland

Other specified special examinations

1.3

6.9

636

5139

JN2DM

NOMESCO Finland

Lower part of abdomen very extensive MRI examination with Tesla magnet

4.2

6.9

8380/3-C56.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of ovary

13.8

6.9

1820A

ICD-9 Finland

Malignant neoplasm of body of uterus, Corpus uteri, except isthmus[CARCINOMA ENDOMETRII]

13.8

6.9

JN3BG

NOMESCO Finland

MRI examination of abdomen with high intensity magnet

13.8

6.9

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

1.7

6.9

131

778

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

3.1

6.9

114

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

2.2

6.9

292

ZYC01

NOMESCO Finland

Remote contact by phone

1.8

6.8

118

678

C18.99

ICD-10 Finland

Malignant tumor in unspecified location in the colon other or unspecified histology

4.8

6.8

59201

ICD-8 Finland

Calculus of kidney and ureter, Calculus renis

8.3

6.8

C08CA13

ATC

lercanidipine; oral

1.4

6.8

384

2894

TJW99

NOMESCO Finland

Other minor procedure in gastrointestinal endoscopy

10.9

6.8

SPAT1171

SPAT

Bladder puncture

10.9

6.8

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

10.9

6.8

BBA40

NOMESCO Finland

Subtotal parathyroidectomy

5.0

6.8

SPAT1234

SPAT

Support of social functional capacity

1.6

6.8

150

926

C56.79

ICD-10 Finland

Other epithelial carcinoma of the ovary

9.3

6.8

C53.11

ICD-10 Finland

Squamous cell carcinoma and exocervix

9.3

6.8

A41.4

ICD-10 Finland

Sepsis due to anaerobes

6.1

6.8

L04AA05

ATC

[U] tacrolimus; systemic

40.1

6.8

75322

ICD-8 Finland

Congenital anomalies of urinary system, Hydronephrosis, obstructione non indicata

40.1

6.8

N18.3

ICD-10 Finland

Chronic kidney disease, stage 3

40.1

6.8

G04AA01

ATC

3.2

6.8

N08.0*A41.9

ICD-10 Finland

Glomerular disease in unspecified septicemia

16.7

6.7

K59.1

ICD-10 Finland

Functional diarrhoea

1.7

6.7

138

837

H02AB09

ATC

hydrocortisone; systemic

2.2

6.7

289

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

2.6

6.7

168

75340

ICD-8 Finland

Congenital anomalies of urinary system, Ureter sive pelvis renalis duplex

22.5

6.7

JAL96

NOMESCO Finland

Other excision of lesion of peritoneum

22.5

6.7

I79.2*E10.5

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy

22.5

6.7

5850B

ICD-9 Finland

Chronic renal failure[INSUFFICIENTIA RENIS CHRONICA CUM URAEMIA]

22.5

6.7

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.5

6.6

221

1507

D70.89

ICD-10 Finland

Neutropenic splenomegaly

2.8

6.6

139

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.7

6.6

125

740

K50.9

ICD-10 Finland

Crohn disease, unspecified

2.5

6.6

187

ZXK00

NOMESCO Finland

Conversion from percutaneous endoscopic to open procedure

3.4

6.6

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.8

6.6

112

642

N30.3

ICD-10 Finland

Trigonitis

12.2

6.6

8480/3-C18.1

ICD-O-3

Mucinous adenocarcinoma of appendix

12.2

6.6

JGB07

NOMESCO Finland

Laparoscopic partial proctectomy with total excision of mesorectum

4.6

6.6

WC115

NOMESCO Finland

Cytostatic therapy of local tumor recidive with multiple drugs

8.7

6.5

K65.8

ICD-10 Finland

Other peritonitis

8.7

6.5

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

2.8

6.5

141

L01BB01

ATC

10.0

6.5

Q61.3

ICD-10 Finland

Polycystic kidney, unspecified

6.8

6.5

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

5.0

6.5

R52.9

ICD-10 Finland

Pain, unspecified

1.5

6.5

233

1616

121

Kela drug reimbursment

Severe hypofunction of sexual glands

2.3

6.5

239

JFF26

NOMESCO Finland

Sigmoidostomy

6.2

6.5

R34

ICD-10 Finland

Anuria and oliguria

6.2

6.5

7186

FHL

Ureteroplasty, narrowing and resection (includes neoimplantation)

69.9

6.4

N11.0

ICD-10 Finland

Nonobstructive reflux-associated chronic pyelonephritis

69.9

6.4

C53.99

ICD-10 Finland

Malignant tumor in unspecified localization in cervix, unspecified histology

69.9

6.4

N36.0

ICD-10 Finland

Urethral fistula

69.9

6.4

4AA09

NOMESCO Finland

69.9

6.4

L01BC53

ATC

tegafur, combinations; systemic

7.4

6.4

XX7FT

NOMESCO Finland

Radioyttrium therapy with connected antibody

7.4

6.4

JN5AN

NOMESCO Finland

Total body isotope imaging

14.3

6.4

C67.5

ICD-10 Finland

Malignant neoplasm: Bladder neck

14.3

6.4

R60.1

ICD-10 Finland

Generalized oedema

4.1

6.4

ZX108

NOMESCO Finland

Inhalation

3.7

6.4

C54.9

ICD-10 Finland

Malignant neoplasm: Corpus uteri, unspecified

6.5

6.3

C18.10

ICD-10 Finland

Malignant tumor of the appendix without histology

6.5

6.3

JFH10

NOMESCO Finland

Total colectomy and ileostomy

6.5

6.3

N08.2*D89.80

ICD-10 Finland

Immunoglobulin A (IgA) nephropathy

5.2

6.3

KCH00

NOMESCO Finland

Suture of bladder

5.9

6.3

1510

Kela drug reimbursment

Niraparib

11.0

6.3

3009

Kela drug reimbursment

Niraparib

11.0

6.3

LCA06

NOMESCO Finland

Biopsy of endometrium

1.4

6.3

267

1914

TK824

NOMESCO Finland

Replacement of peritoneal dialysis catheter extension tube

18.0

6.3

JFB20

NOMESCO Finland

Ileocaecal resection

3.8

6.3

N17.1

ICD-10 Finland

Acute renal failure with acute cortical necrosis

+∞

6.2

5935A

ICD-9 Finland

Other disorders of kidney and ureter, Hydroureter

+∞

6.2

KBH06

NOMESCO Finland

Ureteroureterostomy

+∞

6.2

59110

ICD-8 Finland

+∞

6.2

KAH70

NOMESCO Finland

Freeing of adhesions of ureteropelvic junction

+∞

6.2

59098

ICD-8 Finland

Infections of kidney, Alia definita

+∞

6.2

PBU99

NOMESCO Finland

Other repair after previous reconstruction of arteries of upper extremity

+∞

6.2

59001

ICD-8 Finland

Infections of kidney, Pyelonephrosis chronica

+∞

6.2

KCD98

NOMESCO Finland

Other cystoscopic partial excision of bladder or destruction of tumour of bladder

+∞

6.2

7119

FHL

Other measure in this category

26.7

6.2

B01AA03

ATC

warfarin; systemic

1.3

6.2

679

5600

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

2.1

6.2

305

XW4AT

NOMESCO Finland

Biopsy of other inner organ with ultrasound guidance

4.8

6.2

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.5

6.2

204

1391

F43.29

ICD-10 Finland

Adaptation disorder UNS

2.3

6.2

240

UJF92

NOMESCO Finland

Capsular endoscopy

2.3

6.2

240

JMA10

NOMESCO Finland

Transabdominal total splenectomy

4.1

6.2

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

3.0

6.2

112

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

2.2

6.2

261

C67.1

ICD-10 Finland

Malignant neoplasm: Dome of bladder

6.3

6.1

N80.81

ICD-10 Finland

Endometriosis in sacrouteral ligament

5.7

6.1

8130/3-C67.9

ICD-O-3

Papillary urothelial carcinoma of bladder, NOS

5.7

6.1

ZY010

NOMESCO Finland

Hospital outpatient

1.7

6.1

110

644

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

2.0

6.1

358

SPAT1151

SPAT

Treatment of major wounds

2.6

6.1

152

A10BH02

ATC

vildagliptin; oral

2.2

6.1

266

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

3.2

6.1

WF003

NOMESCO Finland

Adjuvant radiotherapy

1.7

6.1

106

615

N82.0

ICD-10 Finland

Vesicovaginal fistula

12.5

6.1

PC5YT

NOMESCO Finland

Stenting of renal artery

12.5

6.1

8120/3-C65.9

ICD-O-3

Transitional cell carcinoma, NOS, of renal pelvis

12.5

6.1

I80.20

ICD-10 Finland

Phlebitis and thrombophlebitis in the iliac vein

3.7

6.1

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

1.9

6.1

388

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

2.5

6.0

179

XW000

NOMESCO Finland

Bone marrow biopsy

1.7

6.0

116

692

JFB53

NOMESCO Finland

Resection of sigmoid colon with partial proctectomy

10.0

6.0

G95.8

ICD-10 Finland

Other specified diseases of spinal cord

6.7

6.0

A08.1

ICD-10 Finland

Acute gastroenteropathy due to Norovirus

6.7

6.0

A07DA03

ATC

loperamide; oral

1.7

6.0

105

607

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1290

3835

4.26

307.65

11.0

3.3

mmol/l

1.1

1.0

17.48

1237

3507

(3026008) Bacteria identified in Urine by Culture

2567

10299

4.31

307.65

6.3

2.7

—

(3020779) Urea [Moles/volume] in Serum or Plasma

1093

2403

5.63

307.65

11.8

3.7

mmol/l

12.3

7.8

63.21

1058

2268

(3000850) Epithelial cells [#/volume] in Urine

1807

7445

3.33

307.65

5.4

2.2

e6/l

5.2

0.01

1677

6423

(3002582) Erythrocytes [#/volume] in Urine

2322

10812

3.28

307.65

7.3

2.8

e6/l

177.3

90.1

2.20

2030

8203

(3023368) Bacteria identified in Blood by Culture

2249

9461

3.65

307.65

7.7

3.7

—

(3049717) Cytology report of Urine Cyto stain

760

1415

6.22

307.65

3.5

2.7

—

(3026782) Osmolality of Urine

1751

6967

3.42

307.65

5.7

2.3

mosm/kgh2o

513.9

567.3

23.54

1606

5842

(3018095) Leukocytes [#/volume] in Urine

2446

12653

2.96

285.17

8.4

3.2

e6/l

297.8

76.1

11.57

2080

8837

(3030467) Casts [#/volume] in Urine by Automated count

2077

9880

2.98

281.96

6.7

2.7

e6/l

0.4

0.68

1788

7327

(36304419) Bacteria [Presence] in Urine

1967

9587

2.82

247.77

6.6

2.7

—

(3031040) Bacteria [#/volume] in Urine by Automated count

3589

24064

3.11

238.89

10.1

4.0

e6/l

865.1

1492.1

0.70

345

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3031

18701

2.76

234.56

11.1

5.7

umol/l

9.9

12.0

21.63

2935

17680

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1331

5485

2.99

226.15

5.3

3.0

mmol/l

0.8

6.45

1273

5059

(3024561) Albumin [Mass/volume] in Serum or Plasma

2662

15650

2.63

222.96

9.5

4.0

g/l

32.8

35.5

86.96

2547

14410

(3021447) Carbon dioxide [Partial pressure] in Venous blood

902

2997

3.49

219.80

7.3

2.6

kpa

5.7

5.8

3.78

878

2904

(3012544) pH of Venous blood

925

3132

3.44

218.69

7.1

2.7

7.4

—

(3032080) INR in Blood by Coagulation assay

2595

15209

2.59

216.56

10.7

9.3

inr

1.2

1.3

11.70

837

4271

(3002032) Base excess in Venous blood by calculation

893

2989

3.46

214.74

7.3

2.6

mmol/l

1.2

2.2

9.92

696

2402

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2795

17105

2.58

210.69

6.8

3.9

—

(3044640) Blood type and Crossmatch panel - Blood

2124

11454

2.57

209.43

3.9

2.3

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2044

11133

2.49

193.24

3.6

2.4

u/l

56.5

58.8

1.48

1933

10198

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2872

18241

2.49

192.93

13.3

5.2

mmol/l

1.2

3.47

2397

15327

(3037467) Urinalysis macro (dipstick) panel - Urine

3558

25019

2.77

192.06

8.5

3.8

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

1095

4502

2.87

182.24

9.1

6.1

mmol/l

105.0

104.5

2.54

1068

4389

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

453

1057

4.64

179.69

3.6

3.0

u/ml

0.3

0.4

2.81

231

609

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

680

2146

3.54

177.24

6.9

2.3

ng/l

135.8

68.9

20.67

598

1786

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

709

2301

3.45

176.88

1.9

1.5

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

515

1351

4.16

175.31

2.1

1.8

ug/l

2.8

1.9

0.75

470

1166

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1109

4844

2.69

162.17

4.0

1.8

g/l

2.1

2.4

28.26

1052

4448

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

332

652

5.40

161.01

5.5

3.1

mg/l

1.9

1.2

27.43

308

597

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1213

5588

2.58

158.72

6.3

2.6

e6/l

2.5

2.2

0.48

823

3023

(3000991) Gas panel - Venous blood

750

2681

3.14

158.64

10.6

7.0

—

(3021601) Nitrite [Presence] in Urine by Test strip

2685

17444

2.27

158.14

8.8

4.4

estimate

0.0

0.50

740

3226

(3035350) Ketones [Presence] in Urine by Test strip

2679

17404

2.26

157.60

6.6

3.3

estimate

0.0

0.00

743

3160

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1044

4492

2.70

156.74

4.2

1.9

21.2

23.0

3.61

927

3794

(3009261) Glucose [Presence] in Urine by Test strip

2703

17671

2.26

155.92

6.7

3.3

estimate

0.0

1.34

741

3119

(3022948) Iron [Moles/volume] in Serum or Plasma

1164

5309

2.59

155.07

4.0

1.9

umol/l

11.0

13.3

23.05

1109

4879

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2567

16504

2.23

153.36

11.1

4.8

mmol/l

1.2

0.16

2411

14789

(3013826) Glucose [Moles/volume] in Serum or Plasma

3109

21705

2.29

150.25

7.8

4.2

mmol/l

6.8

6.7

0.49

2987

20216

(3013650) Neutrophils [#/volume] in Blood by Automated count

3006

20765

2.25

148.06

16.5

8.2

e9/l

4.5

4.1

14.82

2764

17935

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

235

358

6.86

147.70

6.1

6.3

mg/l

12.7

11.3

3.37

222

337

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

924

3871

2.73

145.17

6.3

3.9

ug/l

29.5

25.7

0.16

780

3170

(1616796) Gas panel - Central venous blood

315

651

5.12

143.94

5.4

2.9

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

572

1858

3.37

140.99

6.1

2.4

e6/l

0.3

0.69

563

1811

(3041096) Erythrocytes [Presence] in Urine by Automated

1661

9290

2.22

136.27

6.2

3.0

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1165

5606

2.44

136.15

2.9

1.9

29.8

29.9

0.33

1142

5441

(3024354) Oxygen [Partial pressure] in Venous blood

686

2553

2.98

133.87

5.8

2.6

kpa

4.7

4.5

1.88

662

2470

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1208

5990

2.37

131.34

5.8

2.5

e6/l

3.3

1.2

0.55

812

3389

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

913

3983

2.61

131.06

4.3

4.1

u/l

250.6

241.8

0.74

883

3735

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

587

2078

3.09

124.68

6.1

2.9

kpa

4.9

5.2

13.53

554

1902

(3009343) pH of Capillary blood

579

2043

3.09

123.63

6.1

3.0

7.4

5.70

103

204

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

566

1973

3.13

123.40

6.1

2.9

mmol/l

0.7

2.0

8.49

380

1461

(3022096) Basophils/100 leukocytes in Blood

2422

16199

2.03

118.89

7.3

5.6

0.6

0.7

11.87

2319

15010

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2116

13509

2.03

118.13

7.1

3.5

—

(3019069) Monocytes/100 leukocytes in Blood

2480

16784

2.02

117.09

7.6

5.9

8.8

0.34

2374

15594

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

454

1431

3.41

116.63

8.3

2.5

mmol/l

23.0

24.5

15.01

412

1270

(3026250) Tacrolimus [Mass/volume] in Blood

20.14

115.96

40.1

27.6

ug/l

6.9

7.8

0.77

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1131

5717

2.29

115.65

2.2

1.7

—

(4035726)

751

3157

2.64

115.11

1.5

1.3

—

(3002030) Lymphocytes/100 leukocytes in Blood

2519

17213

2.00

114.90

7.5

5.7

23.7

27.8

55.59

2405

15913

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3611

28151

2.24

114.51

14.5

6.8

u/l

88.5

78.5

17.73

3496

26305

(3006504) Eosinophils/100 leukocytes in Blood

2456

16688

1.99

113.25

7.3

5.6

2.6

2.9

6.46

2343

15438

(3018418) pH of Serum or Plasma

1757

10636

2.04

112.25

8.4

3.1

7.4

8.84

486

1939

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1524

8766

2.10

111.82

3.7

2.2

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1947

12251

2.01

111.37

6.8

3.1

mmol/l

2.3

2.4

6.13

1762

10546

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

469

1562

3.23

109.97

8.4

3.1

u/ml

106.1

56.0

2.02

458

1500

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

542

1974

2.97

108.86

1.8

1.4

—

(42870588) Differential panel, method unspecified - Blood

1919

12093

2.00

108.55

6.9

5.4

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

481

1648

3.14

107.45

6.3

2.6

mmol/l

23.9

25.5

15.32

470

1596

(3015235) Bicarbonate [Moles/volume] in Capillary blood

308

797

4.07

105.61

4.2

2.8

mmol/l

22.8

25.6

16.65

279

679

(40768446) Kidney Pathology biopsy report

25.05

105.28

2.4

1.1

—

(3018010) Neutrophils/100 leukocytes in Blood

2456

16977

1.94

104.55

7.3

5.5

61.0

57.2

38.09

2353

15769

(3013290) Carbon dioxide [Partial pressure] in Blood

280

693

4.23

101.89

5.6

3.6

kpa

4.8

5.1

6.89

275

681

(3012501) Base excess in Blood by calculation

280

693

4.23

101.89

5.6

3.6

mmol/l

2.2

2.7

2.20

163

472

(3027315) Oxygen [Partial pressure] in Blood

280

697

4.21

101.10

5.6

3.6

kpa

9.0

8.5

3.66

274

685

(3042936) Bacteria identified in Isolate by Culture

975

4874

2.26

100.79

2.6

1.8

—

(3027945) Reticulocytes/100 erythrocytes in Blood

864

4137

2.34

98.71

2.9

2.3

1.8

1.7

0.47

771

3612

(3006315) Basophils [#/volume] in Blood

2535

17921

1.91

98.54

7.0

5.4

e9/l

0.0

4.65

2244

15292

(3001604) Monocytes [#/volume] in Blood

2525

17829

1.90

98.50

7.0

5.4

e9/l

0.6

7.02

2230

15203

(40767503) Oxygen content in Capillary blood by calculation

268

664

4.22

97.33

3.3

2.1

15.8

16.4

1.12

156

308

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

216

453

4.95

96.63

6.1

1.6

—

(3019198) Lymphocytes [#/volume] in Blood

2572

18346

1.89

96.40

7.2

5.4

e9/l

1.7

1.9

5.70

2308

15956

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1540

9295

1.98

95.87

2.5

2.1

mg/l

3.2

2.9

2.54

1337

7862

(3013115) Eosinophils [#/volume] in Blood

2587

18538

1.89

95.04

7.3

5.6

e9/l

0.2

1.53

2301

16074

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

526

2026

2.80

94.73

8.1

6.8

mmol/l

23.5

25.1

18.78

520

2013

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

314

889

3.71

94.61

1.5

1.2

—

(3021901) Oxygen saturation in Capillary blood

240

559

4.47

94.42

3.9

2.5

—

(3037121) Protein [Mass/volume] in Urine

351

1075

3.45

93.85

5.5

2.7

g/l

0.4

0.2

1.46

251

404

(3028626) Oxygen [Partial pressure] in Capillary blood

280

737

3.98

93.62

5.3

3.1

kpa

8.4

8.1

2.29

265

675

(3010421) pH of Blood

296

833

3.73

89.91

6.0

3.4

7.4

6.33

276

681

(3014111) Lactate [Moles/volume] in Serum or Plasma

671

3001

2.44

88.74

7.6

6.1

mmol/l

1.4

1.3

0.17

647

2886

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

770

3668

2.32

88.21

5.9

3.0

—

(3033658) Prothrombin time (PT) actual/Normal

1475

9057

1.92

85.25

7.0

3.6

91.6

87.7

7.81

1445

8840

(40761536) Microorganisms panel - Urine sediment

657

2995

2.39

82.93

7.8

3.4

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

516

2102

2.64

82.81

5.2

2.6

g/l

118.2

130.8

27.91

504

2044

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

692

3241

2.33

82.05

2.5

2.1

g/l

0.2

4.37

644

3011

(3029937) Albumin [Presence] in Urine by Test strip

1527

9585

1.88

81.78

7.4

3.6

estimate

0.0

0.51

651

3129

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

651

2981

2.38

81.24

8.1

3.0

mmol/l

1.2

2.61

602

2552

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

400

1443

2.94

80.93

1.7

1.6

g/l

1.9

1.5

9.46

352

1212

(3042733) HLA Ab [Presence] in Serum

17.80

80.10

5.4

2.8

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2149

15087

1.79

78.92

3.9

2.6

ug/l

199.7

125.9

13.97

2014

13790

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2032

14119

1.78

76.59

4.6

3.5

ng/l

44.8

84.1

0.65

1590

9925

(3010375) cycloSPORINE [Mass/volume] in Blood

11.00

73.01

36.1

26.3

ug/l

99.8

136.6

3.22

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

363

1317

2.90

72.50

4.5

3.2

u/ml

597.4

4129.8

0.95

325

1111

(3026493) Urate [Moles/volume] in Serum or Plasma

1442

9164

1.83

72.45

3.6

2.4

umol/l

4785.9

5667.2

0.25

1290

7791

(3023520) Reticulocytes [#/volume] in Blood

632

3066

2.23

68.11

3.0

2.3

e9/l

66.1

69.0

1.12

491

2307

(3020630) Protein [Mass/volume] in Serum or Plasma

594

2816

2.27

67.66

2.7

2.4

g/l

65.0

66.5

4.80

552

2549

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

207

560

3.82

66.39

8.4

4.1

iu/ml

662.7

3988.9

0.49

(3017181) Myelocytes/100 leukocytes in Blood

622

3032

2.21

66.13

4.1

4.0

1.1

1.0

0.54

271

776

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1659

11228

1.74

65.84

4.2

3.0

u/l

34.7

35.7

0.15

1573

10599

(3007853) Bacteria identified in Skin by Aerobe culture

756

3996

2.06

65.08

2.1

1.6

—

(3003396) Base excess in Arterial blood by calculation

777

4150

2.05

65.01

7.9

6.5

mmol/l

0.2

1.2

7.38

589

3229

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

743

3939

2.05

63.31

2.1

1.7

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

741

3946

2.04

62.29

2.0

1.6

—

(3016502) Oxygen saturation in Arterial blood

712

3738

2.07

62.22

8.2

6.8

95.8

95.6

0.38

680

3600

(3027801) Oxygen [Partial pressure] in Arterial blood

770

4165

2.02

61.95

7.9

6.5

kpa

13.0

12.4

2.17

727

3963

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

770

4166

2.02

61.90

7.9

6.5

kpa

4.9

5.1

4.79

730

3964

(3021440) Promyelocytes/100 leukocytes in Blood

591

2897

2.19

61.72

4.1

4.0

0.2

0.1

0.36

257

716

(3022313) Gas panel - Capillary blood

377

1515

2.62

61.61

7.0

3.1

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

169

421

4.13

60.75

4.3

2.4

u/ml

649.7

2550.6

—

(3021589) Normoblasts [#/volume] in Blood

2158

15972

1.65

59.36

19.2

8.8

e9/l

0.0

0.03

1843

12981

(3013512) EKG study

1582

10903

1.68

56.70

5.0

3.9

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

384

1627

2.48

56.06

4.3

2.2

1.2

0.05

378

1616

(3002256) Pathology report gross observation

846

4887

1.89

55.55

1.4

1.3

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

377

1595

2.48

55.19

4.3

2.2

0.7

2.67

372

1514

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

269

967

2.89

54.39

2.6

2.5

g/l

3.8

3.6

1.19

262

915

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

260

921

2.93

53.99

2.0

1.5

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

644

3442

2.01

52.98

8.6

7.1

g/l

111.8

122.8

35.53

621

3308

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

604

3172

2.04

52.14

3.0

2.3

u/l

37.3

38.0

0.10

546

2694

(3027570) Oxalate [Moles/time] in 24 hour Urine

31.13

51.83

1.5

1.2

umol/24h

322.9

342.2

0.09

(3002179) Metamyelocytes/100 leukocytes in Blood

545

2765

2.10

51.62

4.1

3.8

0.8

0.6

1.17

190

554

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

705

3923

1.94

51.52

2.9

2.7

umol/l

9.0

0.01

609

3414

(4281824)

129

299

4.41

50.97

1.2

1.1

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

251

904

2.88

50.54

2.1

3.3

ratio

1.4

3.0

1.04

(1761482) Bacteria [#/volume] in Urine by Culture

266

993

2.78

50.08

7.2

3.7

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4081

36406

1.95

50.01

34.6

12.9

mg/l

33.1

24.0

50.82

3727

28684

(3025159) Blasts/100 leukocytes in Blood

537

2744

2.08

49.82

4.2

4.0

0.0

0.4

1.23

217

599

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

254

934

2.82

49.20

2.2

3.3

mg/l

45.4

43.0

0.12

197

776

(3034860) Kappa light chains.free [Mass/volume] in Serum

254

936

2.81

49.00

2.2

3.3

mg/l

60.4

46.4

1.69

195

773

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

221

766

2.98

47.68

4.8

3.4

u/ml

994.4

854.2

0.06

203

709

(3004588) Protein electrophoresis panel - Serum or Plasma

463

2289

2.14

46.73

1.9

2.3

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1162

7714

1.67

46.24

5.7

4.3

—

(40758558) Short blood count panel - Blood

1312

9012

1.63

45.54

13.5

6.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

215

756

2.93

45.20

3.5

2.0

g/l

123.5

130.8

3.57

184

517

(3003694) ABO and Rh group [Type] in Blood

1414

9965

1.60

43.84

1.6

1.4

—

(40761535) Cells panel - Urine sediment

557

3013

1.96

43.80

6.1

3.0

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1142

7653

1.65

43.38

1.9

1.7

mg/l

2.0

1.2

4.68

944

5830

(3004809) Band form neutrophils/100 leukocytes in Blood

171

541

3.24

43.11

3.2

3.6

1.7

0.02

143

395

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1535

11083

1.57

42.65

3.1

2.9

ng/l

2758.3

1204.8

12.20

1346

9509

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

254

1005

2.62

42.60

2.2

2.3

90.9

90.7

0.03

242

946

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

195

675

2.97

42.15

1.7

1.4

pmol/l

289.6

167.1

1.45

190

660

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1039

6865

1.66

41.44

5.7

2.9

mmol/l

2.5

2.4

10.34

932

6002

(40760888) Immunoglobulin light chains.free panel - Serum

194

677

2.95

41.33

2.4

3.6

—

(3019309) Folate [Moles/volume] in Red Blood Cells

1063

7101

1.64

40.48

2.0

1.7

nmol/l

1218.0

1151.7

1.33

846

5276

(3024932) HLA-DR beta [Type]

8.86

40.15

1.0

1.2

—

(40768804) Tissue Pathology biopsy report

1931

14811

1.52

40.05

2.5

2.1

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

237

936

2.61

39.88

2.6

2.5

212.1

187.4

3.51

228

894

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

175

588

3.05

39.86

2.2

1.2

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

439

2254

2.05

39.85

9.3

8.1

0.7

0.15

430

2238

(3024471) HLA-A [Type]

8.70

39.61

1.0

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1549

11351

1.55

39.61

5.2

3.7

mg/mmol

23.0

5.5

16.71

1155

7022

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

7.29

38.95

2.0

2.7

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

159

515

3.16

38.56

2.2

1.2

u/ml

139.1

118.9

0.47

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

436

2267

2.02

38.16

9.3

8.0

1.2

1.4

2.77

427

2255

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

372

1852

2.10

36.60

9.4

8.5

mmol/l

23.3

24.5

7.66

351

1714

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

385

1944

2.07

36.48

10.1

8.8

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

323

1524

2.20

36.47

6.0

4.6

1.5

1.6

1.05

305

1425

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

406

2093

2.03

36.34

2.0

1.6

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

319

1501

2.21

36.26

6.1

4.6

0.8

0.9

2.93

303

1403

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

730

4545

1.72

35.88

2.2

1.5

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

168

589

2.92

35.50

2.1

1.2

u/ml

11.9

15.1

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

587

3453

1.80

35.12

2.2

1.4

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

290

1332

2.25

34.94

8.0

3.1

mmol/l

23.7

25.0

8.80

273

1222

(3024928) Oxygen saturation in Venous blood

174

631

2.83

34.56

4.3

2.4

—

(3019060) Gas panel - Arterial blood

448

2436

1.93

34.34

5.6

4.3

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

140

463

3.09

32.80

3.1

2.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

152

530

2.93

32.45

1.6

1.2

u/ml

272.5

276.3

0.05

301

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

161

580

2.84

32.39

1.6

1.2

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

195

776

2.58

32.30

1.7

1.5

—

(3000330) Specific gravity of Urine by Test strip

365

1911

1.99

31.17

6.8

3.0

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1832

14413

1.45

30.90

2.9

2.1

nmol/l

76.2

77.9

1.85

1669

12762

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

304

1496

2.10

30.76

2.3

1.8

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1467

11076

1.47

30.65

2.3

2.1

u/l

258.0

213.2

0.29

1399

10321

(3020876) Protein [Mass/time] in 24 hour Urine

225

3.97

30.61

1.9

2.0

g/24h

1.9

1.4

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

208

876

2.44

30.56

1.5

1.2

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

154

560

2.81

30.45

1.8

1.6

—

(3023183) Ammonium ion [Moles/volume] in Plasma

166

628

2.70

30.43

2.1

2.4

umol/l

30.9

35.1

1.20

136

528

(3009508) Creatinine [Moles/volume] in Urine

1498

11402

1.46

29.83

4.3

2.9

mmol/l

6.8

7.7

15.88

1276

9446

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

282

1365

2.13

29.78

2.1

1.7

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1150

8309

1.51

29.70

6.0

3.3

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

4090

37696

1.68

29.48

38.4

15.1

mmol/l

139.2

139.7

35.11

4021

36645

(3036481) Cortisol [Moles/volume] in Serum or Plasma

505

2989

1.77

29.33

2.9

2.2

nmol/l

379.1

374.3

0.20

481

2715

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

197

4.11

29.29

1.1

u/ml

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

187

765

2.50

29.25

1.8

1.5

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

165

636

2.65

29.16

4.3

3.7

61.1

57.2

2.65

165

636

(3008152) Bicarbonate [Moles/volume] in Arterial blood

419

2354

1.86

28.89

8.4

6.2

mmol/l

23.5

24.7

7.37

389

2196

(3023103) Potassium [Moles/volume] in Serum or Plasma

4091

37797

1.66

28.10

38.9

15.2

mmol/l

4.0

27.72

4015

36682

(3012565) Volume of 24 hour Urine

126

4.89

27.83

2.5

1696.7

2102.5

2.19

108

(3012516) Albumin [Mass/volume] in Urine

1416

10784

1.45

27.65

4.3

3.0

mg/l

291.4

276.3

0.06

1064

6680

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

479

2840

1.76

27.59

4.9

2.4

ml/min/173m2

49.0

69.4

31.34

288

1110

(3025941) Bacteria identified in Stool by Culture

341

1827

1.93

27.16

1.3

1.2

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1194

8829

1.47

27.09

1.7

1.5

nmol/l

18.7

20.3

2.58

1055

7461

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

127

444

2.91

27.03

1.8

1.5

—

(3036489) Thrombin time

259

1279

2.09

25.93

2.2

2.1

22.3

21.4

0.90

237

1137

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

107

349

3.11

25.72

1.8

1.6

—

(3043410) Blood group antigens tested for on Red Blood Cells

5.43

25.21

2.8

1.4

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

162

4.18

25.17

1.4

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

163

4.16

24.97

2.8

3.1

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2656

22805

1.38

24.86

3.9

2.9

u/l

59.1

48.0

5.26

2519

21007

(46235355) HIV 1 and 2 tests - Meaningful Use set

794

5483

1.54

24.80

2.3

1.7

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

174

748

2.38

24.45

1.6

1.3

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

208

3.70

24.08

1.5

1.3

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

251

3.43

24.03

1.8

1.5

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

291

3.24

23.98

1.2

u/l

76.2

59.1

0.76

199

(3019225) pH of Specimen

573

3699

1.63

23.85

8.5

3.4

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

129

487

2.70

23.80

1.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

121

442

2.78

23.78

1.7

1.4

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

166

708

2.39

23.75

1.6

1.3

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

120

437

2.79

23.72

1.7

1.4

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

6.33

23.51

1.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

118

430

2.79

23.31

1.6

1.4

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

165

708

2.38

23.30

1.6

1.3

—

(3051651) Icteric interference index of Serum or Plasma

182

3.83

23.06

5.5

3.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

205

3.65

23.04

1.6

1.3

—

(3047181) Lactate [Moles/volume] in Blood

230

1137

2.08

22.97

6.6

5.4

mmol/l

1.3

0.52

201

1007

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

300

3.14

22.82

2.8

1.9

u/field

1.8

1.6

0.12

114

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

118

435

2.76

22.81

1.7

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

118

435

2.76

22.81

1.7

1.4

—

(3003434) Protein [Mass/volume] in Pleural fluid

128

493

2.64

22.72

1.5

1.4

g/l

32.7

32.6

0.02

116

443

(3005988) Vibrio sp identified in Specimen by Organism specific culture

118

436

2.75

22.71

1.7

1.4

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

230

1142

2.07

22.70

2.5

2.1

ug/l

349.0

343.1

0.03

224

1073

(3037756) Immunofixation for Serum or Plasma

158

674

2.39

22.61

1.5

1.6

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

984

7226

1.46

22.51

4.3

3.6

ng/l

303.3

464.9

1.18

790

5775

(40768806) Pleura Pathology biopsy report

108

383

2.86

22.45

1.5

1.6

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

117

438

2.71

21.97

1.6

1.4

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

378

2236

1.75

21.81

1.5

1.4

—

(3016750) Collection duration of Urine

185

3.72

21.76

2.6

1.8

min

503.6

500.7

0.07

129

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1071

8037

1.43

21.70

1.8

1.7

pmol/l

16036080.9

35634524.4

0.58

898

6592

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

5.98

21.66

1.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

110

402

2.78

21.63

5.5

21.7

mmol/l

7.3

7.4

0.22

327

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

150

4.04

21.60

1.7

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

150

4.04

21.60

1.6

1.3

—

(3005719) IgG [Mass/volume] in Serum or Plasma

401

2419

1.72

21.57

3.0

2.6

g/l

10.3

10.6

0.69

376

2181

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

3710

34038

1.44

21.27

33.1

12.4

ml/min/173m2

68.7

80.4

125.19

3354

27902

(3013727) Leukocytes other/100 leukocytes in Blood

114

4.51

21.22

3.3

3.7

57.9

53.7

0.61

109

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

136

558

2.48

21.21

1.6

1.4

—

(3022217) INR in Platelet poor plasma by Coagulation assay

739

5193

1.50

20.95

22.0

26.8

inr

1.3

1.4

2.56

140

727

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

211

1046

2.07

20.92

1.6

1.5

titre

78.8

308.5

1.83

(3036525) Urea [Moles/time] in 24 hour Urine

+∞

20.84

3.5

0.0

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

312

2.99

20.75

2.8

2.2

—

(3022621) pH of Urine by Test strip

394

2397

1.70

20.52

4.4

2.8

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

272

3.13

20.51

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

293

3.04

20.49

2.3

2.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

101

364

2.81

20.41

2.8

3.8

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

135

4.11

20.31

1.1

u/l

111.3

83.2

0.70

100

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

124

498

2.53

20.24

1.5

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

113

434

2.64

20.21

1.5

1.4

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

4.92

19.89

1.3

1.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

163

749

2.22

19.65

1.7

1.5

—

(3004775) Volume in Urine collected for unspecified duration

269

3.08

19.60

2.7

2.1

731.6

575.7

2.89

163

(3012898) Urea [Moles/volume] in Urine

12.71

19.43

1.6

1.3

mmol/l

102.1

205.7

2.06

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

168

786

2.18

19.37

1.6

1.5

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

136

4.01

19.28

1.1

u/l

44.4

26.5

0.69

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

173

3.62

19.16

1.7

1.5

—

(3013707) Erythrocyte sedimentation rate by Westergren method

3024

27019

1.34

19.02

4.7

3.9

mm/h

18.7

11.9

57.58

2813

24808

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

198

3.42

18.99

1.6

1.5

—

(3028026) IgM [Mass/volume] in Serum or Plasma

320

1879

1.75

18.91

1.7

1.9

g/l

1.2

1.4

1.81

300

1692

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

318

2.87

18.89

1.3

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

231

1228

1.93

18.81

2.6

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

185

3.49

18.76

3.0

1.6

u/field

3.2

2.9

0.11

133

(3020891) Body temperature

267

1493

1.84

18.59

6.5

4.1

—

(3033799) Differential panel - Peritoneal fluid

5.03

18.53

1.4

1.7

—

(3052851) Hemolysis interference index of Serum or Plasma

203

1039

2.00

18.45

4.7

3.2

—

(3018405) Lactate [Moles/volume] in Arterial blood

242

1317

1.88

18.35

4.6

3.6

mmol/l

1.3

1.4

0.22

231

1302

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

174

3.54

18.26

1.7

1.5

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

113

4.19

17.87

1.3

1.4

2.9

3.1

0.02

(3011648) Oxygen content in Venous blood

245

3.05

17.45

3.3

2.1

10.2

10.8

0.65

245

(3029634) Reagin Ab [Titer] in Serum by VDRL

102

402

2.57

17.36

2.1

1.8

—

3.6

—

(3019150) Specific gravity of Urine by Refractometry

1021

7858

1.38

17.31

7.0

3.7

kg/l

1.0

0.20

193

1176

(3012441) Differential panel - Pleural fluid

374

2.63

17.26

1.4

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

193

995

1.98

17.20

3.0

2.1

u/l

5295.2

5306.2

0.00

403

(40761511) CBC panel - Blood by Automated count

4011

37727

1.44

16.62

31.9

12.5

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

337

2.67

16.44

1.2

1.3

u/l

578.1

318.6

0.83

321

(3002385) Erythrocyte distribution width [Ratio]

3277

29878

1.32

16.38

39.9

16.1

14.3

13.7

72.02

3231

29160

(3022145) Colonoscopy Study observation

566

3957

1.49

16.19

1.4

1.3

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

234

1321

1.81

15.81

1.8

2.1

g/l

4.0

3.8

1.61

165

935

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

234

1322

1.81

15.77

1.8

2.1

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

234

1322

1.81

15.77

1.8

2.1

g/l

7.8

7.3

2.93

170

983

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

138

3.65

15.75

1.3

1.4

60.8

64.3

0.29

112

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

170

865

2.00

15.75

1.4

1.6

g/l

0.3

0.2

2.09

165

817

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

220

1224

1.84

15.59

1.9

2.1

g/l

10.7

10.2

0.98

193

1029

(3045414) Leukocytes [Presence] in Urine

267

1588

1.72

15.08

2.5

1.8

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

477

3275

1.51

14.86

3.2

2.7

ng/l

249.5

191.7

2.25

439

2965

(40768797) Stomach Pathology biopsy report

667

4889

1.42

14.82

1.3

1.2

—

(3036782) Glucose [Moles/volume] in Pleural fluid

338

2.57

14.78

1.3

1.4

mmol/l

6.2

0.01

312

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1810

15413

1.28

14.63

2.2

2.0

pmol/l

92.3

94.5

1.23

1082

7985

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

135

652

2.10

14.44

1.6

1.7

—

(3044889) 12 lead EKG panel

2849

25686

1.28

14.38

4.6

3.8

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

241

2.85

14.28

1.9

1.6

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

5.84

13.98

2.1

1.2

ng/l

194.4

80.4

2.33

(3019977) pH of Arterial blood

196

3.04

13.91

2.7

2.5

7.4

1.59

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

170

904

1.91

13.89

1.4

1.6

g/l

1.2

0.16

164

851

(3051611) Lipemic interference index of Serum or Plasma

345

2.49

13.69

5.1

3.1

—

(3006576) Bicarbonate [Moles/volume] in Blood

100

3.92

13.67

7.4

6.2

mmol/l

23.4

25.3

1.79

(3003181) Sodium [Moles/volume] in Urine

122

583

2.12

13.44

1.5

1.3

mmol/l

59.9

67.9

1.22

477

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

4.37

13.31

3.8

1.6

ug/l

20.5

2.1

0.84

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

471

3308

1.47

13.07

2.5

2.3

ug/l

5.8

7.0

1.20

407

2876

(3014148) Varicella zoster virus Ab [Titer] in Serum

324

2.49

12.97

1.1

1.2

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

5.34

12.75

1.2

1.3

16.6

7.3

0.96

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4065

38685

1.39

12.51

17.9

9.8

u/l

24.1

25.9

6.63

3942

37081

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

162

881

1.87

12.40

3.3

2.2

ug/min

178.9

76.1

1.61

116

513

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

183

2.97

12.34

1.5

1.6

u/l

8.1

6.6

0.23

(3045424) Erythrocytes [Presence] in Urine

116

564

2.08

12.25

1.8

1.4

—

(3035637) Corticotropin [Mass/volume] in Plasma

414

2.27

12.24

1.6

—

(3039000) Anion gap in Blood

152

820

1.88

11.94

8.2

6.1

mmol/l

11.2

11.1

0.20

136

732

(3018572) Chloride [Moles/volume] in Blood

152

821

1.88

11.90

8.2

6.1

mmol/l

105.7

105.3

0.42

136

733

(3023199) Leukocytes [#/volume] in Pleural fluid

452

2.19

11.85

1.5

1.4

e6/l

923.6

1918.3

3.84

339

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

208

1237

1.71

11.80

1.8

2.1

g/l

3.2

3.1

1.56

167

958

(3023487) Leukocytes [#/volume] in Peritoneal fluid

3.69

11.64

1.6

1.8

e6/l

886.4

8381.8

0.48

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

30.09

11.63

5.9

1.2

—

(3004451) EKG impression Narrative

163

3.03

11.58

1.2

—

(40768441) Liver Pathology biopsy report

223

2.67

11.06

1.1

1.3

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

191

1133

1.71

10.96

2.2

g/l

0.9

1.0

0.17

169

970

(3043409) Potassium [Moles/volume] in Arterial blood

192

1143

1.71

10.88

5.2

3.8

mmol/l

4.1

3.9

3.50

162

1072

(3044242) Glucose [Moles/volume] in Arterial blood

192

2.78

10.78

2.1

2.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

21.49

10.67

1.3

1.0

—

(3044007) Cell count panel - Peritoneal fluid

3.85

10.64

1.6

1.5

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

3.74

10.56

1.3

1.7

e6/l

2111.3

10934.0

1.33

(3017354) Segmented neutrophils/100 leukocytes in Blood

340

2.29

10.39

2.9

3.3

64.5

55.8

2.45

202

(3044927) Protein electrophoresis panel - Urine

304

2.36

10.28

1.3

1.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2332

21000

1.22

10.04

3.1

2.8

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

169

998

1.72

9.89

1.8

2.1

g/l

0.0

0.35

158

913

(3022493) Free Hemoglobin [Mass/volume] in Plasma

130

3.09

9.88

1.7

5.8

mg/l

72.8

75.9

0.07

(3042631) Mycobacterium sp identified in Specimen

100

500

2.02

9.87

2.2

2.8

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

215

1353

1.62

9.86

2.0

1.8

u/l

37.6

39.0

0.53

196

1185

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

279

2.39

9.85

1.6

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

279

2.39

9.85

1.6

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

279

2.39

9.85

1.6

1.5

—

(3012989) Citrate [Moles/time] in 24 hour Urine

26.06

9.80

1.5

1.4

mmol/24h

1.7

2.7

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

362

2.20

9.78

1.1

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

251

2.45

9.66

1.6

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

171

1021

1.70

9.62

1.5

1.4

ug/g

242.6

276.6

1.20

107

589

(3028308) Erythrocytes [#/volume] in Pleural fluid

412

2.11

9.53

1.4

e6/l

37488.1

69875.3

0.62

250

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

104

3.29

9.28

3.3

2.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

104

3.29

9.28

3.3

2.1

—

(3007164) IgA [Mass/volume] in Serum or Plasma

792

6372

1.29

9.28

1.5

1.4

g/l

2.6

2.4

0.97

515

3731

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

491

2.00

9.28

1.1

—

(3007461) Platelets [#/volume] in Blood

4183

40303

1.36

9.26

47.8

19.6

e9/l

252.7

246.1

7.41

4092

39141

(3045788) Cell count panel - Pleural fluid

353

2.17

9.13

1.5

1.4

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1637

14323

1.22

9.12

6.9

5.3

ug/l

12.4

3.4

3.50

1469

12741

(3024731) MCV [Entitic volume]

4183

40320

1.35

9.08

47.6

19.6

91.2

0.43

4120

39648

(3035941) MCH [Entitic mass]

4183

40320

1.35

9.08

47.5

19.5

30.1

30.4

19.93

4119

39648

(3017732) Neutrophils [#/volume] in Blood

337

2381

1.45

9.05

3.4

3.0

e9/l

4.5

4.1

1.43

263

1815

(3026361) Erythrocytes [#/volume] in Blood

4183

40323

1.35

9.05

47.7

19.6

e12/l

4.2

4.5

178.54

4081

39028

(3000963) Hemoglobin [Mass/volume] in Blood

4184

40336

1.35

9.03

48.1

19.7

g/l

125.2

135.5

251.89

4126

39668

(3010813) Leukocytes [#/volume] in Blood

4183

40330

1.35

8.98

47.8

19.7

e9/l

7.2

6.8

21.16

4085

39032

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

170

1035

1.67

8.92

1.8

2.0

g/l

35.8

38.0

4.89

152

879

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

513

1.95

8.87

1.2

—

(3009542) Hematocrit [Volume Fraction] of Blood

3462

32638

1.23

8.76

30.8

14.5

36.4

39.5

44.32

2222

22493

(21494890) Protein electrophoresis panel - 24 hour Urine

276

2.30

8.72

1.7

2.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

239

2.40

8.70

1.2

—

(3000494) Fungus identified in Specimen by Culture

538

4140

1.34

8.67

1.6

1.4

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

790

9628

0.78

8.64

1.7

1.6

mmol/l

1.5

1.3

4.91

672

8040

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

154

924

1.69

8.55

1.9

2.1

g/l

0.0

0.00

143

843

(3035880) pH of Pleural fluid

205

2.50

8.53

1.1

1.3

—

(3017704) Immunofixation for Urine

159

2.72

8.49

1.7

1.6

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

3.52

8.23

1.9

2.2

mmol/l

7.8

7.7

0.04

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

151

911

1.68

8.23

1.9

2.1

g/l

0.0

0.00

141

842

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

323

2.15

8.17

1.6

—

(40757494) Bilirubin.total [Moles/volume] in Blood

194

2.49

7.96

2.0

2.2

umol/l

16.5

26.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

377

2782

1.39

7.94

2.3

2.1

nmol/l

7.6

12.3

18.11

311

2432

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

3.43

7.93

1.1

1.3

—

(44790049)

370

2.04

7.77

1.6

1.4

—

(44790047)

370

2.04

7.77

1.6

1.4

—

(44806118)

370

2.04

7.77

1.6

1.4

—

(44790048)

370

2.04

7.77

1.6

1.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

350

2.07

7.75

1.6

—

(3037522) Nuclear Ab [Titer] in Serum

556

4375

1.31

7.63

1.3

titre

597.1

525.7

0.31

937

(21494755) Public health laboratory ask at order entry panel

174

2634

0.65

7.31

1.3

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

+∞

7.29

4.4

0.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

161

2.56

7.25

1.4

1.6

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

161

2.56

7.25

1.4

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

161

2.56

7.25

1.4

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

161

2.56

7.25

1.4

1.6

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

326

2.07

7.23

1.1

1.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

3.93

7.15

2.0

1.3

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

155

983

1.60

6.99

1.3

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

304

2.09

6.96

1.2

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

142

883

1.63

6.94

1.6

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

155

986

1.59

6.91

1.3

1.1

—

(3011412) CD3 cells [#/volume] in Blood

300

2.08

6.81

2.5

e9/l

0.8

1.1

2.42

177

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

6.48

6.77

1.0

1.5

32.3

29.8

—

(3016038) Potassium [Moles/volume] in Urine

223

2.26

6.72

1.4

1.2

mmol/l

32.7

34.3

0.20

190

(42529406) Shigella sp [Presence] in Stool by Culture

155

996

1.58

6.63

1.3

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

219

2.25

6.57

2.2

2.4

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

170

2.42

6.50

1.3

1.2

u/l

18.8

20.5

0.13

140

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

389

1.92

6.47

1.4

1.3

nmol/l

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

134

837

1.62

6.46

1.3

1.2

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

177

2.39

6.44

1.3

1.2

u/l

82.9

81.2

0.04

148

(3024980) IgG subclass 4 [Mass/volume] in Serum

499

1.80

6.37

2.7

1.7

g/l

1.0

0.8

0.56

388

(3047185) IgG [Mass/volume] in Urine

+∞

6.25

1.0

0.0

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

409

1.87

6.21

1.4

1.3

—

(3007566) Smooth muscle Ab [Titer] in Serum

134

851

1.59

6.06

1.3

1.2

titre

82.7

96.3

0.36

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

129

826

1.58

5.66

2.0

1.9

mg/l

11.9

10.6

0.81

120

753

(3051387) C reactive protein [Mass/volume] in Capillary blood

130

838

1.57

5.55

5.0

3.2

mg/l

33.4

28.1

0.81

528

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

243

2.07

5.50

1.3

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

153

2.36

5.46

2.8

2.5

—

(3025549) Creatine [Moles/time] in 24 hour Urine

5.57

5.32

1.2

1.4

—

(3017569) Oxygen content in Arterial blood

181

2.22

5.27

1.6

2.3

—

(3026389) Candida sp identified in Specimen by Organism specific culture

462

1.74

5.25

1.3

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

169

2.26

5.22

2.2

2.4

102.1

96.3

0.39

162

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

+∞

5.21

5.6

0.0

umol/l

738.8

—

(3014271) Vancomycin [Susceptibility]

189

2.18

5.17

2.5

3.0

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

222

2.08

5.17

1.0

1.1

—

(40768795) Lymph node Pathology biopsy report

333

1.87

5.16

1.3

1.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

2.69

5.16

2.9

2.3

—

(3023511) Choriogonadotropin [Units/volume] in Urine

527

1.68

5.08

1.4

1.3

—

(3045142) Bone marrow Pathology biopsy report

415

1.77

5.07

1.3

—

(3000012) Reticulocyte production index

198

2.13

5.02

1.4

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

118

1772

0.66

4.86

1.3

1.4

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

229

2.02

4.79

2.3

10.7

13.3

0.79

105

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

113

2.49

4.78

1.1

miu/ml

1675.8

1639.0

0.05

113

(3036603) Volume of Urine

196

2.10

4.75

1.8

1.5

1618.6

1848.6

0.62

(3048689) Calprotectin [Mass/mass] in Stool

492

4045

1.24

4.72

2.4

2.2

ug/g

174.3

139.5

1.01

387

3163

(21494814) CD8 cells/100 lymphocytes in Specimen

121

2.41

4.63

3.0

2.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

148

2.24

4.49

1.2

1.1

—

(4062490)

307

1.83

4.43

1.4

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

199

2669

0.73

4.37

1.6

1.7

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

130

891

1.47

4.26

1.1

1.3

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

507

1.63

4.25

1.2

u/ml

1.9

3.8

1.30

162

(3001019) Free T4 and TSH panel - Serum or Plasma

1492

0.66

4.20

1.9

1.7

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

572

1.58

4.18

1.8

1.6

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

3.42

4.18

2.6

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

640

1.54

4.06

1.6

1.5

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

2.86

4.05

1.3

2.6

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

129

2.26

4.05

1.5

1.7

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

129

2.26

4.05

1.5

1.7

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

10.01

4.01

1.0

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

595

1.56

3.98

1.6

1.5

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

130

2.24

3.98

1.5

1.7

—

(3003327) Ova and parasites identified in Stool by Light microscopy

148

1058

1.41

3.91

1.7

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

3.43

3.90

6.2

1.9

u/field

0.2

0.6

1.62

(3028192) IgG subclass 2 [Mass/volume] in Serum

306

1.77

3.88

1.5

1.4

g/l

2.8

3.0

0.27

220

(3024139) IgG subclass 3 [Mass/volume] in Serum

306

1.77

3.88

1.5

1.4

g/l

0.5

0.4

0.34

219

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

599

1.55

3.88

1.3

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.51

3.87

1.3

1.0

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

307

1.77

3.84

1.5

1.4

g/l

7.9

6.6

1.72

222

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

307

1.77

3.84

1.4

1.5

—

(4268621)

346

1.71

3.77

2.3

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

208

1.93

3.76

1.3

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

134

2.17

3.72

2.7

2.3

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

5.63

3.65

3.0

4.2

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

100

673

1.50

3.64

3.6

1.5

nmol/l

1.0

0.8

2.62

567

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

497

1.58

3.63

1.2

u/ml

3.5

5.1

0.97

212

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

3.26

3.62

1.2

1.3

ng/l

82.8

64.5

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

553

1.55

3.62

1.7

1.3

u/l

56.0

37.5

0.29

473

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

211

1.90

3.62

1.3

—

(3014051) Protein [Presence] in Urine by Test strip

121

848

1.44

3.59

3.2

2.1

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

257

2031

1.28

3.51

3.2

3.3

pmol/l

4.2

4.5

5.95

235

1784

(4024509)

347

1.68

3.48

1.8

1.5

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.48

3.46

1.2

1.4

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

113

2.22

3.41

1.1

1.3

ug/l

145.6

221.2

0.25

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

4.74

3.23

1.0

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

833

7430

1.15

3.16

1.3

u/ml

1.0

1.9

2.98

224

1908

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

250

1997

1.27

3.16

2.5

—

(3047189) Immunofixation for 24 hour Urine

137

2.05

3.16

1.3

1.7

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

491

1.54

3.15

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

2.47

3.12

1.7

1.2

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

390

1.60

3.10

1.5

66.3

57.8

0.91

235

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

313

1.67

3.09

1.0

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

510

1.52

3.08

1.1

—

(3008295) Osmolality of Serum or Plasma

360

1.62

3.06

1.3

1.4

mosm/kgh2o

279.5

278.0

0.19

271

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3425

35285

0.89

3.06

4.5

4.4

mmol/l

1.4

1.5

12.86

3107

32154

(3024869) Neuronal Ab [Presence] in Serum

2.51

3.03

1.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

119

2.11

3.03

1.6

umol/l

87.3

148.2

0.96

(3023410) Appearance of Cerebral spinal fluid

316

1.65

2.99

1.5

1.6

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

114

2.11

2.93

1.2

1.4

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

121

884

1.38

2.91

1.2

1.3

miu/ml

207.7

224.7

0.18

419

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

3.34

2.90

1.2

1.1

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

2.51

2.87

2.1

3.6

ng/l

156.5

156.4

—

(3052592) Norovirus Ag [Presence] in Stool

2.51

2.87

1.2

1.3

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

496

1.50

2.83

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

361

1.59

2.80

1.9

2.3

umol/l

6.7

6.0

0.16

253

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

216

1.77

2.79

2.1

2.5

e6/l

422.9

497.1

0.66

181

(3023323) Follitropin [Units/volume] in Serum or Plasma

161

1237

1.31

2.79

1.6

1.4

iu/l

33.8

27.1

1.41

143

1043

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3543

36376

0.89

2.78

4.9

mmol/l

2.6

2.7

12.43

3226

33190

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

474

1.51

2.77

2.4

2.0

mg/l

35.4

24.8

0.59

110

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

8.34

2.75

1.2

1.0

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.86

2.74

1.7

2.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

104

2.12

2.74

1.9

1.8

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

5.01

2.72

1.0

—

(3011985) Renin [Units/volume] in Plasma

428

1.53

2.71

1.9

1.5

mu/l

106.0

57.4

0.45

380

(3032057) Clostridioides difficile [Presence] in Stool

2.43

2.70

2.3

1.7

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

469

1.50

2.70

1.1

115.8

114.7

0.11

417

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

502

1.48

2.68

1.5

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3462

35567

0.90

2.67

4.6

4.4

mmol/l

4.5

4.6

9.40

3161

32649

(3014891) Appearance of Pleural fluid

2.66

2.62

1.8

1.5

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

265

2182

1.23

2.61

1.2

iu/ml

123.4

135.8

0.19

801

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

221

1.73

2.60

2.7

2.3

e6/l

459.4

648.7

1.27

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1180

0.71

2.59

1.5

1.6

mg/l

5.2

3.5

0.82

822

(3017509) Phencyclidine [Presence] in Urine

4.00

2.56

1.6

1.3

—

(36303858) Crystals [Presence] in Urine

7.15

2.55

1.4

1.0

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

2.73

2.54

1.7

1.4

ug/l

129.3

122.3

0.06

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

101

2.08

2.52

1.1

91.8

86.1

0.41

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

437

1.49

2.49

1.2

1.1

g/l

1.6

1.5

0.70

387

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.67

2.45

1.1

—

(3028433) Virus identified in Specimen by Culture

110

2.00

2.40

1.4

1.1

—

(3011325) HIV 1+2 Ab [Presence] in Serum

5.00

2.40

1.2

1.0

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.34

2.39

1.1

1.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1240

11511

1.11

2.36

5.1

4.6

23.8

21.8

3.78

712

5895

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

183

1.75

2.35

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

330

2808

1.19

2.34

2.0

1.6

—

(3004616) Nuclear Ab [Presence] in Serum

419

1.49

2.33

1.2

—

(4306422)

486

1.45

2.31

1.2

—

(44806420)

105

2.00

2.30

2.5

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.86

2.30

2.2

2.4

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

388

1.50

2.30

3.7

3.3

—

(3034426) Prothrombin time (PT)

112

1.97

2.30

1.2

1.3

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.69

2.27

1.1

—

(3006462) Nitrate [Presence] in Urine

185

1.73

2.27

5.4

3.5

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

2.28

2.24

1.1

1.2

76.8

69.1

—

(40757373) Influenza virus identified in Isolate

2.28

2.24

1.3

1.6

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

240

1.63

2.22

1.1

1.2

titre

84.3

148.7

—

(4198724)

100

2.00

2.20

1.4

1.6

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

712

1.36

2.18

1.9

1.8

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

3.34

2.18

3.3

3.8

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

2.24

2.17

1.3

1.2

100.5

74.8

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

585

1.39

2.17

2.0

1.8

—

(3032773) Endomysium IgG Ab [Titer] in Serum

276

1.56

2.08

1.0

1.1

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

5.00

2.07

1.2

1.0

—

(3020393) Adenovirus Ag [Presence] in Stool

2.91

2.07

1.2

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.08

2.06

1.0

1.5

—

(4211845)

200

1.65

2.01

5.3

3.4

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

741

1.33

1.99

1.3

1.4

e6/l

4.8

21.3

1.44

577

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

741

1.33

1.99

1.3

1.5

e6/l

240.6

1180.6

1.66

611

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

3.34

1.96

9.9

8.6

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

4.55

1.94

1.2

—

(40768800) Prostate Pathology biopsy report

124

973

1.28

1.93

1.1

1.2

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.57

1.92

2.2

2.3

—

(3008536) Aspergillus sp Ab [Presence] in Serum

2.12

1.92

1.9

1.8

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

165

1344

1.24

1.88

1.6

1.5

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

119

933

1.28

1.88

1.4

1.3

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.09

1.86

1.2

1.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

107

1.87

1.86

1.3

1.2

g/l

38.9

40.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

100

1.90

1.85

3.0

2.5

—

(3048879) Bone marrow aspiration report

100

1.90

1.85

1.6

1.8

—

(3046861) Legionella sp Ag [Presence] in Urine

3.53

1.83

1.0

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

3.53

1.83

1.0

1.9

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

167

1.68

1.83

1.1

1.6

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

108

1.86

1.81

1.2

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

352

0.57

1.80

1.0

u/ml

4.2

0.4

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

194

1620

1.21

1.76

1.4

1.3

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

102

1.87

1.76

1.1

1.3

83.0

81.7

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

404

1.42

1.76

1.9

1.4

pmol/l

556.3

284.8

0.60

311

(3010144) Erythrocytes [#/volume] in Synovial fluid

322

1.46

1.73

1.4

1.3

e6/l

13180.9

105180.6

1.86

228

(3006270) Folate [Moles/volume] in Blood

339

1.45

1.72

1.2

nmol/l

327.1

348.9

0.24

282

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

3.85

1.71

1.0

1.2

nmol/l

263.6

239.2

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

103

1.85

1.71

1.4

1.2

99.2

98.2

0.04

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

333

2920

1.15

1.69

1.9

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

125

1002

1.25

1.68

1.6

iu/ml

0.5

14.3

1.07

217

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

183

2181

0.83

1.67

1.3

au/ml

31.5

55.8

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

180

1.61

1.66

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

548

1.34

1.62

1.1

1.0

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

108

856

1.27

1.61

1.4

1.3

mg/l

471.7

530.1

0.83

101

811

(3014133) Dog dander IgE Ab [Units/volume] in Serum

425

0.63

1.59

1.1

u/ml

7.1

3.8

—

162

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.50

1.59

1.5

2.5

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

320

1.44

1.59

1.5

1.4

22.2

31.3

1.11

193

(4034850)

1226

0.79

1.56

16.2

10.1

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

2.28

1.53

1.1

1.4

nmol/l

7.4

492113.5

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

107

854

1.26

1.52

1.7

1.4

u/l

14.2

9.8

1.57

101

692

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

217

1.52

1.51

1.8

1.6

mmol/l

8.0

7.9

0.14

137

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

885

8254

1.09

1.50

3.4

3.2

ug/l

1.2

0.8

6.35

633

5713

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.86

1.50

1.1

1.2

—

(3020650) Glucose [Presence] in Urine

1.86

1.50

2.7

1.4

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

537

0.69

1.49

1.0

1.1

u/ml

2.2

5.3

2.55

275

(3029396) Erythrocyte agglutination [Presence] in Blood

2.00

1.48

3.1

3.0

—

(3016018) Differential panel - Cerebral spinal fluid

334

1.41

1.47

1.2

1.4

—

(3000034) Microalbumin [Mass/volume] in Urine

327

1.41

1.44

3.3

2.9

mg/l

143.8

29.2

1.19

252

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

3.13

1.44

1.4

1.6

mg/l

2.0

0.6

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

3.13

1.44

1.4

1.6

mg/l

0.2

0.7

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

3.13

1.44

1.4

1.6

mg/l

0.3

1.1

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

3.13

1.44

1.4

1.6

mg/l

0.8

1.6

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

253

1.47

1.42

1.1

1.2

u/ml

5.0

2.1

—

(3009871) Measles virus Ab [Titer] in Serum

1.82

1.41

1.9

1.7

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

326

0.61

1.40

6.2

4.9

u/ml

163.4

79.5

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.42

1.39

2.1

2.2

—

(3000492) Spirometry study

287

3245

0.88

1.38

1.5

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

152

1275

1.20

1.38

1.8

1.6

—

(3008898) HLA-B27 [Presence]

1060

0.79

1.37

1.0

1.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.94

1.36

1.0

1.1

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

2.94

1.36

1.4

1.6

mg/l

1.8

0.4

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.94

1.36

1.0

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

514

0.70

1.36

1.0

1.1

u/ml

0.3

1.3

2.06

220

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

594

0.72

1.34

1.1

u/ml

6.2

1.7

0.47

242

(3023420) DNA double strand Ab [Units/volume] in Serum

307

1.40

1.33

1.4

1.5

—

20.4

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

128

1.64

1.33

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

129

1.63

1.29

1.2

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.78

1.28

1.2

1.1

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

751

1.24

1.3

mmol/l

3.6

3.8

1.12

701

(3009466) Valproate [Moles/volume] in Serum or Plasma

467

1.31

1.24

7.3

4.6

umol/l

361.9

352.1

0.21

395

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

209

2394

0.87

1.24

2.3

2.4

au/ml

17.5

21.4

—

121

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

228

1.45

1.23

1.8

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

100

1.70

1.23

1.1

1.2

—

(3044290) Cell count panel - Cerebral spinal fluid

682

1.25

1.21

1.3

1.4

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.16

1.21

1.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

522

1.29

1.21

1.4

1.3

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

200

1740

1.16

1.20

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

101

828

1.22

1.19

1.5

1.9

iu/l

4.9

4.5

0.08

289

(4212803)

0.00

1.15

0.0

1.1

—

(4094501)

968

0.80

1.15

1.1

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

159

1.51

1.11

1.1

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

159

1.51

1.11

1.1

1.6

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.26

1.10

1.1

1.3

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.38

1.09

1.0

—

(3030313) Adrenal Ab [Titer] in Serum

2.38

1.09

1.0

—

(3001729) Color of Synovial fluid

2.19

1.08

1.6

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.19

1.08

1.4

2.2

—

(21494434) Karyotype in Bone marrow

321

1.34

1.07

1.2

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

511

5512

0.92

1.07

1.2

u/ml

18.1

13.0

0.27

180

2114

(3020491) Glucose [Moles/volume] in Blood

287

1.36

1.06

1.9

2.0

mmol/l

6.6

6.5

0.13

187

(3023419) Bacteria identified in Sputum by Culture

471

1.28

1.05

2.0

2.6

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3350

34044

0.94

1.04

4.2

3.9

mmol/l

1.4

1.3

12.32

3031

30793

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

356

3247

1.10

1.03

2.0

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2807

27473

1.05

1.03

4.2

3.9

pmol/l

14.9

0.82

2562

24732

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

272

1.36

1.02

1.1

1.2

u/ml

23.0

58.8

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.97

0.0

4.8

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

0.00

0.97

0.0

1.4

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.97

0.0

1.0

—

(40765096) Chromosome analysis panel by Banding

108

1.58

0.96

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

648

0.78

0.96

1.5

1.7

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

182

1.43

0.95

3.3

2.7

40.0

37.6

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

386

0.72

0.93

1.1

u/ml

1.5

4.7

—

157

(1002224) Polysomnography panel

104

1222

0.85

0.92

1.1

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

269

1.34

0.92

1.1

u/ml

92.4

76.8

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.67

0.91

1.3

1.2

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

270

1.34

0.90

1.4

1.5

u/ml

27.8

22.3

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

108

921

1.18

0.90

1.1

1.2

u/ml

34.8

46.4

—

(3021788) Differential panel - Synovial fluid

610

1.22

0.89

1.6

1.5

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

202

1.39

0.89

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

202

1.39

0.89

1.0

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

160

1.44

0.88

4.7

1.4

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.91

0.88

1.4

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

177

1.41

0.88

1.2

1.1

ratio

1.1

1.0

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

494

0.77

0.87

1.1

u/ml

2.1

2.4

—

121

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.86

0.87

1.3

1.5

—

(44806071)

2.00

0.87

1.2

1.0

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

548

5833

0.93

0.85

1.2

1.3

iu/ml

31.3

34.1

0.20

182

1762

(3022689) Creatine [Moles/volume] in Urine

104

1.54

0.84

1.7

1.3

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

263

2395

1.10

0.83

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

918

0.84

0.83

1.4

1.5

—

(44813793)

226

0.66

0.82

1.3

1.0

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

534

1.22

0.82

1.1

iu/ml

11.7

1194.9

0.55

113

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

1.61

0.81

1.2

1.4

ug/l

0.5

0.4

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

256

2806

0.91

0.81

1.3

1.4

—

(40768443) Skin Pathology biopsy report

176

1571

1.12

0.80

1.2

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

215

1.35

0.80

1.0

1.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

834

1.17

0.76

1.6

e6/l

38269.6

12877.1

1.17

594

(3034891) Synovial lining cells/100 cells in Synovial fluid

157

1.40

0.76

1.5

1.3

3.6

4.2

—

(4027681)

183

1.37

0.75

1.2

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

2.08

0.74

1.0

1.1

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

1.64

0.73

1.1

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

1.64

0.73

1.1

98.2

101.0

—

(3044009) aPTT.lupus sensitive (LA screen)

2.00

0.72

1.0

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.80

0.72

1.0

1.2

—

(3000285) Sodium [Moles/volume] in Blood

1.61

0.72

1.8

1.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

858

1.16

0.72

1.2

u/ml

6.2

7.6

0.14

145

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

480

1.21

0.71

1.4

1.3

mmol/l

7.3

7.4

0.14

348

(3019174) dRVVT (LA screen)

1.92

0.70

1.0

1.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

177

1.36

0.70

1.0

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

169

1.36

0.69

1.1

—

(36660697) Celiac disease serology panel - Serum

286

2645

1.09

0.68

1.2

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

845

1.15

0.67

1.1

1.2

u/ml

2.7

2.6

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

763

1.16

0.65

3.5

3.1

nmol/l

0.8

0.02

577

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.54

0.65

3.4

2.1

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.72

0.64

1.2

1.0

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.72

0.64

1.4

3.4

—

(3044941) Cell count panel - Synovial fluid

543

1.18

0.62

1.5

1.4

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.55

0.62

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.67

0.61

1.2

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

253

1.27

0.61

2.8

2.4

—

(3006653) Thiamine [Moles/volume] in Blood

191

1.31

0.60

1.4

1.2

nmol/l

136.4

136.2

0.01

191

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

132

1.37

0.57

1.1

113.3

89.4

—

101

(44816559) Phosphatidylethanol [Mass/volume] in Blood

603

0.84

0.56

1.5

1.3

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.58

0.56

1.0

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

257

1.25

0.55

1.5

1.3

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

177

1.30

0.54

2.0

2.2

ug/min

122.3

73.2

—

(4133840)

1.46

0.54

1.1

1.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

195

1.28

0.54

3.7

4.0

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

693

1.14

0.53

1.1

1.2

u/ml

1.4

4.9

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

855

0.88

0.53

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

215

0.74

0.52

1.0

1.2

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

250

1.24

0.52

1.4

1.3

promille

1.5

1.3

0.34

191

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

0.61

0.52

1.5

1.6

ug/l

9.0

8.8

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

153

1.31

0.50

1.2

1.1

u/ml

—

34.6

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3358

33253

1.03

0.49

4.9

4.6

mu/l

2.0

2.1

0.69

3081

30112

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

257

0.78

0.49

1.0

ng/l

340.6

311.8

0.25

165

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

257

0.78

0.49

1.0

ng/l

52.0

44.7

0.42

162

(3041806) Other cells [#/volume] in Blood by Manual count

108

0.65

0.48

1.3

1.7

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

256

0.78

0.47

1.0

ng/l

668.1

668.4

0.00

159

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.49

0.47

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.49

0.47

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.49

0.47

1.0

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

211

0.76

0.47

7.4

6.8

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

281

1.21

0.47

1.4

1.3

mmol/l

11.4

11.5

—

(1617658) Protocol used for examination of sentinel lymph nodes

255

0.78

0.46

1.0

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

420

1.17

0.46

3.0

2.9

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.38

0.46

1.0

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.37

0.43

1.0

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.40

0.42

1.8

1.3

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.63

0.42

1.0

1.1

—

(4015189)

1.36

0.41

1.2

2.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1078

0.91

0.41

1.8

1.7

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

0.41

0.0

1.1

—

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

1.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

326

0.83

0.40

1.3

1.2

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.40

0.0

1.0

—

(3018001) Oat IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.0

—

0.3

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

465

0.86

0.40

1.2

1.1

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.0

—

8.7

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.36

0.40

1.0

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.43

0.39

1.6

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.43

0.39

3.0

2.6

—

(3051101) Glucose [Moles/volume] in Cord blood

1.41

0.39

6.2

6.7

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

124

1.29

0.38

1.1

1.2

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.39

0.38

1.4

2.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.33

0.37

1.2

—

(3027035) Albumin [Mass/time] in 24 hour Urine

1.35

0.37

1.6

1.4

—

823.2

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.27

0.36

1.1

1.2

—

(40768793) Breast Pathology biopsy report

755

0.90

0.36

1.2

1.3

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

180

1.22

0.35

1.0

1.2

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

1.43

0.35

2.2

3.3

—

(4010399)

268

2553

1.05

0.34

1.4

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

1.33

0.33

5.0

5.6

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

1.33

0.33

2.5

2.8

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

303

1.16

0.32

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.28

0.32

1.0

1.2

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

107

992

1.08

0.31

1.8

1.7

—

(21491868) Cryoglobulin [Mass/volume] in Serum

110

1.27

0.31

1.0

1.1

—

0.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

480

4645

1.04

0.31

4.4

4.5

32.9

0.00

359

3013

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

389

0.87

0.30

1.9

1.5

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

129

1.24

0.30

1.5

2.2

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

130

1.23

0.28

1.1

1.3

nmol/l

17.6

32.5

—

114

(3021387) Prolactin [Units/volume] in Serum or Plasma

117

1095

1.07

0.28

1.7

1.6

mu/l

294.2

291.9

0.04

104

986

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.32

0.28

29.1

7.0

—

(3000060) B lymphocytes [#/volume] in Blood

1.29

0.28

1.3

2.4

e6/l

160.0

1063.8

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.21

0.26

1.9

1.2

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

347

1.12

0.26

1.7

1.4

ug/l

3.3

4.4

0.56

308

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

171

0.82

0.26

1.0

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

127

0.79

0.25

1.2

1.0

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

571

0.91

0.25

1.5

1.4

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.18

0.24

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

880

1.07

0.24

1.3

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

180

1.17

0.23

1.1

u/l

1.1

—

(3025577) Chromium [Mass/volume] in Blood

243

0.86

0.23

1.9

2.0

ug/l

2.1

2.2

0.08

204

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.25

0.22

1.6

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.25

0.22

1.2

1.6

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.22

0.22

1.0

1.2

—

(3015183) Erythrocyte sedimentation rate

163

1.17

0.21

1.1

1.2

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.21

0.0

1.0

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.0

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3007463) Buprenorphine [Presence] in Urine

0.00

0.21

0.0

4.5

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

296

1.12

0.21

1.0

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

102

0.78

0.21

1.0

1.1

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.21

0.0

1.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.21

0.0

1.2

—

3.5

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

133

1268

1.05

0.20

1.2

u/ml

0.2

1.2

—

120

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

0.00

0.20

0.0

1.0

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.25

0.20

2.5

3.3

—

(3037556) Urate [Mass/volume] in Serum or Plasma

113

0.80

0.20

1.7

1.4

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.20

0.19

1.2

2.1

umol/l

11.0

18.4

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

471

4817

0.98

0.19

15.0

6.6

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

571

5599

1.02

0.19

1.5

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1002

0.95

0.18

1.4

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.13

0.18

2.0

1.1

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

692

0.94

0.17

1.5

1.4

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

247

0.89

0.17

1.3

1.4

pmol/l

85.3

175.7

0.35

(3005033) Fetal Nuchal fold Thickness US

568

0.93

0.17

1.5

1.4

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

494

4845

1.02

0.17

1.5

1.4

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

167

1.14

0.16

1.4

1.3

—

(3002619) Bacteria identified in Specimen by Culture

1.16

0.16

1.6

1.2

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.14

0.16

1.1

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

587

0.94

0.16

1.6

1.5

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

168

1.13

0.15

1.1

1.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

379

3869

0.98

0.15

1.7

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

121

1.16

0.15

1.9

2.3

ug/l

1.1

1.2

0.03

113

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

697

0.95

0.14

1.5

1.4

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

217

1.11

0.14

1.4

1.5

g/l

1.0

0.9

0.43

217

(3029075) Extractable nuclear Ab panel - Serum

0.79

0.14

1.0

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

202

0.89

0.14

1.2

1.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

696

0.95

0.14

1.5

1.4

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

208

1.11

0.14

1.1

iu/ml

6.6

12.3

—

(3036071) Salmonella sp Ab [Titer] in Serum

109

0.83

0.13

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

190

1.11

0.12

1.4

1.2

—

(3024263) Appearance of Synovial fluid

190

1.11

0.12

1.7

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.18

0.12

29.1

6.9

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

425

1.06

0.11

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

183

1787

1.03

0.10

2.0

1.9

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

192

1.09

0.10

1.1

1.4

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

239

0.92

0.10

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

239

0.92

0.10

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

239

0.92

0.10

1.2

1.1

—

(3027008) Opiates [Presence] in Urine

1002

0.97

0.10

2.2

2.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

310

0.94

0.10

1.2

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

1.15

0.09

1.2

20.8

31.3

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

248

0.93

0.09

1.3

1.4

u/ml

2.5

1.2

—

116

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.04

0.09

1.0

1.2

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.04

0.09

1.0

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

696

0.96

0.09

1.5

1.4

—

(3027944) Amphetamines [Presence] in Urine

989

0.97

0.09

1.5

2.0

—

(3013293) Extractable nuclear Ab [Presence] in Serum

1.11

0.09

1.0

1.5

—

(3005322) IgE [Units/volume] in Serum or Plasma

208

2042

1.02

0.08

1.3

u/ml

376.6

213.7

1.15

188

1883

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

107

1.12

0.08

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.03

0.08

1.2

1.0

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

236

0.93

0.08

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

236

0.93

0.08

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

236

0.93

0.08

1.2

1.1

—

(3028300) Cannabinoids [Presence] in Urine

1007

0.97

0.08

2.2

2.0

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

370

3745

0.99

0.08

1.7

1.6

1.5

1.32

326

3264

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

348

0.95

0.08

1.5

1.6

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.07

0.07

1.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

0.84

0.07

1.0

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

167

1.08

0.06

1.6

1.5

—

(3035933) Granulocytes/100 leukocytes in Blood

0.89

0.06

1.4

1.7

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

183

0.93

0.06

1.2

1.1

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

142

0.92

0.06

1.5

2.0

ug/l

20.5

75.1

0.50

129

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

102

0.88

0.06

1.0

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

197

1.07

0.06

10.8

11.8

—

(3050129) First trimester maternal screen panel - Serum or Plasma

860

0.98

0.06

1.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

758

0.98

0.05

1.6

1.5

—

(3003740) Influenza virus B Ag [Presence] in Specimen

445

1.03

0.05

1.0

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

999

0.98

0.05

2.2

2.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

130

0.92

0.04

2.3

2.1

—

(3025130) Human papilloma virus identified in Specimen

367

1.04

0.04

1.7

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3528

35314

1.00

0.03

4.9

4.6

mmol/l

6.0

3.00

3175

31896

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

129

0.93

0.03

1.2

1.4

—

(3016879) Cocaine [Presence] in Urine

924

0.98

0.03

2.2

2.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

451

0.98

0.03

1.3

1.2

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

212

1.04

0.02

1.7

1.4

mmol/l

5.3

5.9

1.77

199

(4146454)

421

1.02

0.02

2.9

2.7

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

780

0.99

0.02

2.3

2.0

—

(1761868) Lipid panel - Serum or Plasma

1188

11859

1.00

0.02

3.3

2.9

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

1.08

0.02

1.0

1.1

u/ml

1.1

2.6

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3339

33409

1.00

0.02

6.9

5.8

mmol/mol

40.5

39.8

3.62

3070

30598

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

432

1.02

0.01

1.0

1.1

u/ml

1.6

2.6

0.74

177

(3003338) MCHC [Mass/volume]

3044

30423

1.00

0.01

40.4

17.4

g/l

329.7

332.5

49.52

3007

30154

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

423

1.02

0.01

1.3

1.4

nmol/l

0.2

0.3

3.02

335

(3002523) Influenza virus A Ag [Presence] in Specimen

444

1.01

0.00

1.0

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

236

1.02

0.00

1.0

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

142

1423

1.00

0.00

1.9

1.8

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

159

1.01

0.00

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

115

1.04

0.00

1.1

1.0

—

(3011288) Drugs identified in Urine by Screen method

680

1.00

0.00

3.2

3.0

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

129

1.01

0.00

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.02

0.00

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

1.02

0.00

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.02

0.00

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.02

0.00

1.1

—

(40758292) HTLV I+II Ab panel - Serum

0.98

0.00

2.0

1.4

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.01

0.00

1.6

1.2

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

0.91

0.00

6.2

7.7

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

0.99

0.00

1.1

1.4

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

0.00

0.0

1.2

—

(3022670) pH of Venous cord blood

0.00

0.0

1.0

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

0.0

1.4

—

1.6

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.93

0.00

1.8

1.6

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

0.0

1.0

—

3685.3

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

0.00

0.0

1.9

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

(3012932) Hazelnut IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

24.2

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

0.0

2.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint N14_HYDRONEPHR and mortality.

Females

Parameter	HR [95% CI]	p-value
N14_HYDRONEPHR	3.907 [3.47, 4.39]	< 0.001
Birth year	0.996 [0.99, 1.0]	0.267

During the follow-up period (1.1.1998 — 31.12.2019), 4573 out of 11586 females with N14_HYDRONEPHR died.

Males

Parameter	HR [95% CI]	p-value
N14_HYDRONEPHR	2.807 [2.45, 3.21]	< 0.001
Birth year	0.982 [0.97, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 5778 out of 12718 males with N14_HYDRONEPHR died.

Mortality risk

Mortality risk for people of age

years, who have N14_HYDRONEPHR.

N-year risk	Females	Males
1	0.35%	0.429%
5	1.824%	2.82%
10	5.494%	7.038%
15	10.627%	12.816%
20	17.581%	20.234%

Relationships between endpoints

↥

Index endpoint: N14_HYDRONEPHR – Hydronephrosis

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Hydronephrosis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints